[{"title01":"Prognostic impact of CEBPA mutational subgroups in adult AML","title02":"Prognostic impact of CEBPA<\/i> mutational subgroups in adult AML","journal":"Leukemia","issue":"2024 Jan 16. doi: 10.1038\/s41375-024-02140-x. Online ahead of print.","author":"Georgi JA, Stasik S, Kramer M, Meggendorfer M, R\u00f6llig C, Haferlach T, Valk P, Linch D, Herold T, Duployez N, Taube F, Middeke JM, Platzbecker U, Serve H, Baldus CD, Muller-Tidow C, Haferlach C, Koch S, Berdel WE, Woermann BJ, Krug U, Braess J, Hiddemann W, Spiekermann K, Boertjes EL, Hills RK, Burnett A, Ehninger G, Metzeler K, Rothenberg-Thurley M, Dufour A, Dombret H, Pautas C, Preudhomme C, Fenwarth L, Bornh\u00e4user M, Gale R, Thiede C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38228680"},{"title01":"OST-01, a natural product from Baccharis coridifolia, targets c-Myc-dependent ribogenesis in acute myeloid leukemia","title02":"OST-01, a natural product from Baccharis coridifolia<\/i>, targets c-Myc-dependent ribogenesis in acute myeloid leukemia","journal":"Leukemia","issue":"2024 Jan 17. doi: 10.1038\/s41375-024-02146-5. Online ahead of print.","author":"Kang H, Hoang DH, Valerio M, Pathak K, Zhang L, Buettner R, Chen F, Estrella K, Graff W, Li Z, Xie J, Horne D, Kuo YH, Zhang B, Pirrotte P, Nguyen LXT, Marcucci G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38233463"},{"title01":"Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer","title02":"Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer","journal":"J Clin Oncol","issue":"2024 Jan 12:JCO2301306. doi: 10.1200\/JCO.23.01306. Online ahead of print.","author":"Stinchcombe TE, Wang X, Damman B, Mentlick J, Landreneau R, Wigle D, Jones DR, Conti M, Ashrafi AS, Liberman M, de Perrot M, Mitchell JD, Keenan R, Bauer T, Miller D, Altorki N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38215351"},{"title01":"Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations","title02":"Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1<\/i> and FLT3<\/i> Mutations","journal":"J Clin Oncol","issue":"2024 Jan 12:JCO2300943. doi: 10.1200\/JCO.23.00943. Online ahead of print.","author":"Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38215358"},{"title01":"Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a distinct genomic profile from that of gamma-delta T-cell large granular lymphocytic leukemia","title02":"Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a distinct genomic profile from that of gamma-delta T-cell large granular lymphocytic leukemia","journal":"Haematologica","issue":"2024 Jan 25. doi: 10.3324\/haematol.2023.283856. Online ahead of print.","author":"Desmares A, Bouzy S, Thonier F, Goustille J, Llamas-Gutierrez F, Genevieve F, Cottin L, Baseggio L, Lemaire P, Lafon CL, Cornillet-Lefebvre P, Galoisy AC, Brouzes C, Rault E, Dindinaud E, Fleury C, Blanc-Jouvan F, Wuilleme S, Bardet V, Fest T, Lamy T, Roussel M, Pannetier M, Pastoret C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38268478"},{"title01":"Social deprivation independently impacts clinical outcomes in patients with chronic lymphocytic leukemia","title02":"Social deprivation independently impacts clinical outcomes in patients with chronic lymphocytic leukemia","journal":"Haematologica","issue":"2024 Jan 25. doi: 10.3324\/haematol.2023.283527. Online ahead of print.","author":"Fegan G, Tod D, Downing A, Elmusharaf N, Pepper C, Fegan C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38268485"},{"title01":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells","title02":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.283597. Online ahead of print.","author":"Hammon K, Renner K, Althammer M, Voll F, Babl N, Decking SM, Siska PJ, Matos C, Conejo ZEC, Mendes K, Einwag F, Siegmund H, Iberl S, Berger RS, Dettmer K, Schoenmehl R, Brochhausen C, Herr W, Oefner PJ, Rehli M, Thomas S, Kreutz M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235501"},{"title01":"CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation","title02":"CSF3R<\/i> P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation","journal":"Br J Haematol","issue":"2024 Jan 23. doi: 10.1111\/bjh.19315. Online ahead of print.","author":"Sun H, Zhu Y, Li J, Zhao L, Yan Z, Zhang S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38262633"},{"title01":"Acute myeloid leukemia with GATA2 and WT1 mutations mimicking acute promyelocytic leukemia","title02":"Acute myeloid leukemia with GATA2<\/i> and WT1<\/i> mutations mimicking acute promyelocytic leukemia","journal":"Blood","issue":"2024 Jan 18;143(3):290.","author":"Chen H, Wang H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38236609"},{"title01":"Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia","title02":"Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia","journal":"Blood","issue":"2024 Jan 19:blood.2023021979. doi: 10.1182\/blood.2023021979. Online ahead of print.","author":"Leung WK, Torres Chavez AG, French-Kim M, Shafer P, Mamonkin M, Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, Watanabe N, Hoyos V, Lulla PD, Leen AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38241630"},{"title01":"Acute leukemia of ambiguous lineage with BCL11B rearrangement","title02":"Acute leukemia of ambiguous lineage with BCL11B<\/i> rearrangement","journal":"Blood","issue":"2024 Jan 11;143(2):183.","author":"Dimopoulos YP, Loghavi S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38206637"},{"title01":"CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment","title02":"CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment","journal":"Blood","issue":"2024 Jan 12:blood.2023021952. doi: 10.1182\/blood.2023021952. Online ahead of print.","author":"Buldini B, Varotto E, Maurer-Granofszky M, Gaipa G, Schumich A, Br\u00fcggemann M, Mejstrikova E, Cazzaniga G, Hrusak O, Szczepanowski M, Scarparo P, Zimmermann M, Strehl S, Schinnerl D, Zaliova M, Karawajew L, Bourquin JP, Feuerstein T, Cario G, Alten J, M\u00f6ricke A, Biffi A, Parasole R, Fagioli F, Valsecchi MG, Biondi A, Locatelli F, Attarbaschi A, Schrappe M, Conter V, Basso G, Dworzak MN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38215390"},{"title01":"Long-term Follow-up from A041202 Shows Continued Efficacy of Ibrutinib Regimens for Older Adults with CLL","title02":"Long-term Follow-up from A041202 Shows Continued Efficacy of Ibrutinib Regimens for Older Adults with CLL","journal":"Blood","issue":"2024 Jan 12:blood.2023021959. doi: 10.1182\/blood.2023021959. Online ahead of print.","author":"Woyach JA, Perez Burbano GE, Ruppert AS, Miller CR, Heerema NA, Zhao W, Wall A, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Stephens DM, Brown JR, Lozanski G, Blachly JS, Nattam S, Larson RA, Erba HP, Litzow MR, Luger SM, Owen C, Kuzma C, Abramson JS, Little RF, Dinner SN, Stone RM, Uy GL, Stock W, Mandrekar SJ, Byrd JC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38215395"},{"title01":"How I Treat: long-term survivors of childhood acute leukemia","title02":"How I Treat: long-term survivors of childhood acute leukemia","journal":"Blood","issue":"2024 Jan 16:blood.2023019804. doi: 10.1182\/blood.2023019804. Online ahead of print.","author":"Saultier P, Michel G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38227937"},{"title01":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","title02":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","journal":"Leukemia","issue":"2024 Jan 18. doi: 10.1038\/s41375-024-02135-8. Online ahead of print.","author":"Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Ros\u00e9e P, Birndt S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38238443"},{"title01":"Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach","title02":"Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach","journal":"Leukemia","issue":"2024 Jan 23. doi: 10.1038\/s41375-024-02147-4. Online ahead of print.","author":"Mandhair HK, Radpour R, Westerhuis M, Banz Y, Humbert M, Arambasic M, Dengjel J, Davies A, Tschan MP, Novak U.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263431"},{"title01":"Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos","title02":"Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos","journal":"Leukemia","issue":"2024 Jan 15. doi: 10.1038\/s41375-024-02150-9. Online ahead of print.","author":"Zala M, Lipinski B, Costechareyre C, Jarrosson L, Teinturier R, Julia E, Lacourr\u00e8ge M, Verney A, Guitton J, Traverse-Glehen A, Bachy E, Salles G, Huet S, Genestier L, Castellani V, Delloye-Bourgeois C, Sujobert P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38225454"},{"title01":"Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a distinct genomic profile from that of gamma-delta T-cell large granular lymphocytic leukemia","title02":"Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a distinct genomic profile from that of gamma-delta T-cell large granular lymphocytic leukemia","journal":"Haematologica","issue":"2024 Jan 25. doi: 10.3324\/haematol.2023.283856. Online ahead of print.","author":"Desmares A, Bouzy S, Thonier F, Goustille J, Llamas-Gutierrez F, Genevieve F, Cottin L, Baseggio L, Lemaire P, Lafon CL, Cornillet-Lefebvre P, Galoisy AC, Brouzes C, Rault E, Dindinaud E, Fleury C, Blanc-Jouvan F, Wuilleme S, Bardet V, Fest T, Lamy T, Roussel M, Pannetier M, Pastoret C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38268478"},{"title01":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","title02":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.284704. Online ahead of print.","author":"Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235513"},{"title01":"The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline","title02":"The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline","journal":"Br J Haematol","issue":"2024 Jan 21. doi: 10.1111\/bjh.19273. Online ahead of print.","author":"Fox CP, Chaganti S, McIlroy G, Barrington SF, Burton C, Cwynarski K, Eyre TA, Illidge T, Kalakonda N, Kuhnl A, McKay P, Davies AJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38247115"},{"title01":"New standards of care for treatment of diffuse large B-cell lymphoma","title02":"New standards of care for treatment of diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2024 Jan 22. doi: 10.1111\/bjh.19295. Online ahead of print.","author":"Abeyakoon C, Gregory GP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38251726"},{"title01":"SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma","title02":"SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma","journal":"Blood","issue":"2024 Jan 18:blood.2023022241. doi: 10.1182\/blood.2023022241. Online ahead of print.","author":"Morsy MHA, Lilienthal I, Lord M, Merrien M, Wasik AM, Amador V, Sureda-G\u00f3mez M, Johansson HJ, Lehti\u00f6 J, Garc\u00eda-Torre B, Martin-Subero JI, Tsesmetzis N, Tao S, Schinazi RF, Kim B, Sorteberg AL, Wickstr\u00f6m M, Sheppard D, Rassidakis GZ, Taylor IA, Christensson B, Campo E, Herold N, Sander B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38237141"},{"title01":"Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation","title02":"Recurrent DDX41<\/i> mutation in very late relapse after allogeneic stem cell transplantation","journal":"Leukemia","issue":"2024 Jan 18. doi: 10.1038\/s41375-024-02152-7. Online ahead of print.","author":"Kambara Y, Sadato D, Toya T, Honda A, Kato S, Hirama C, Haraguchi K, Shimizu H, Najima Y, Kobayashi T, Okuyama Y, Harada H, Takahashi S, Kurokawa M, Harada Y, Doki N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38238444"},{"title01":"Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation","title02":"Recurrent DDX41<\/i> mutation in very late relapse after allogeneic stem cell transplantation","journal":"Leukemia","issue":"2024 Jan 18. doi: 10.1038\/s41375-024-02152-7. Online ahead of print.","author":"Kambara Y, Sadato D, Toya T, Honda A, Kato S, Hirama C, Haraguchi K, Shimizu H, Najima Y, Kobayashi T, Okuyama Y, Harada H, Takahashi S, Kurokawa M, Harada Y, Doki N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38238444"},{"title01":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","title02":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","journal":"Leukemia","issue":"2024 Jan 16. doi: 10.1038\/s41375-024-02136-7. Online ahead of print.","author":"Chen DW, Fan JM, Schrey JM, Mitchell DV, Jung SK, Hurwitz SN, Perez EB, Muraro MJ, Carroll M, Taylor DM, Kurre P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38228679"},{"title01":"Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation","title02":"Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation","journal":"J Clin Oncol","issue":"2024 Jan 17:JCO2301159. doi: 10.1200\/JCO.23.01159. Online ahead of print.","author":"Tobiasson M, Pandzic T, Illman J, Nilsson L, Westr\u00f6m S, Ejerblad E, Olesen G, Bj\u00f6rklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundstr\u00f6m L, von Bahr L, Baltzer-Sollander K, J\u00e4dersten M, Kyt\u00f6l\u00e4 S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SEW, Ebeling F, Cavelier L, Smidstrup Friis L, Dybedal I, Hellstr\u00f6m-Lindberg E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38232336"},{"title01":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","title02":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.284704. Online ahead of print.","author":"Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235513"},{"title01":"Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma","title02":"Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma","journal":"Br J Haematol","issue":"2024 Jan 21. doi: 10.1111\/bjh.19275. Online ahead of print.","author":"Zhu H, Liu J, Gu J, Chen M, Kuang L, Huang B, Zou W, Li J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38246862"},{"title01":"Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report","title02":"Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report","journal":"Br J Haematol","issue":"2024 Jan 11. doi: 10.1111\/bjh.19289. Online ahead of print.","author":"Kunvarjee B, Contreras Yametti GP, Blouin AG, Linder GE, Borge PD, Maryamchik E, Budhai A, Gupta GK, Scaradavou A, Spitzer BG, Curran KJ, Oved JH, Harris AC, Sharma A, Boelens JJ, Cancio MI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38212144"},{"title01":"Sluggish FUS: a key for HSC aging","title02":"Sluggish FUS: a key for HSC aging","journal":"Blood","issue":"2024 Jan 11;143(2):99-100.","author":"Oshima M, Iwama A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38206640"},{"title01":"KBTBD4-mediated Reduction of MYC Is Critical For Hematopoietic Stem Cell Expansion Upon UM171 Treatment","title02":"KBTBD4-mediated Reduction of MYC Is Critical For Hematopoietic Stem Cell Expansion Upon UM171 Treatment","journal":"Blood","issue":"2024 Jan 11:blood.2023021342. doi: 10.1182\/blood.2023021342. Online ahead of print.","author":"Chagraoui J, Girard S, Mallinger L, Mayotte N, Tellechea MF, Sauvageau G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38207291"},{"title01":"Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient \u03b2-catenin\/Hoxa9\/Prmt1 axis","title02":"Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient \u03b2-catenin\/Hoxa9\/Prmt1 axis","journal":"Blood","issue":"2024 Jan 11:blood.2023022082. doi: 10.1182\/blood.2023022082. Online ahead of print.","author":"Lynch J, Troadec E, Fung TK, Gladysz K, Virely C, Lau PNI, Cheung N, Zeisig B, Wong JWH, Lopes M, Huang S, So CWE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38211335"},{"title01":"Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline","title02":"Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline","journal":"Br J Haematol","issue":"2024 Jan 21. doi: 10.1111\/bjh.19236. Online ahead of print.","author":"Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, Griffin M, Hillmen P, Ireland R, Killick S, Mansour S, Mufti G, Potter V, Snowden J, Stanworth S, Zuha R, Marsh J; BSH Committee.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38247114"},{"title01":"The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling","title02":"The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling","journal":"Blood","issue":"2023 Dec 24:blood.2023022724. doi: 10.1182\/blood.2023022724. Online ahead of print.","author":"Sardo U, Perrier P, Cormier K, Sotin M, Personnaz J, Medjbeur T, Desquesnes A, Cannizzo L, Ruiz-Martinez M, Thevenin J, Billor\u00e9 B, Jung G, Abboud E, Peyssonnaux C, Nemeth E, Ginzburg YZ, Ganz T, Kautz L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38232308"},{"title01":"Immune thrombocytopenia (ITP) in pregnancy","title02":"Immune thrombocytopenia (ITP) in pregnancy","journal":"Br J Haematol","issue":"2024 Jan 23. doi: 10.1111\/bjh.19230. Online ahead of print.","author":"Bussel JB, Knightly KA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263610"},{"title01":"Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry","title02":"Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry","journal":"Br J Haematol","issue":"2024 Jan 24. doi: 10.1111\/bjh.19288. Online ahead of print.","author":"Moulis G, Rueter M, Duvivier A, Mah\u00e9vas M, Viallard JF, Comont T, Ch\u00e8ze S, Audia S, Ebbo M, Terriou L, Lega JC, Jeandel PY, Hemim I, Bozzi S, Daak A, Okada H, Bonnotte B, Michel M, Lapeyre-Mestre M, Godeau B; CARMEN-France Investigators Group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38267268"},{"title01":"Dapsone for paediatric chronic immune thrombocytopenia: Short\u00a0report from a tertiary centre in South India","title02":"Dapsone for paediatric chronic immune thrombocytopenia: Short\u00a0report from a tertiary centre in South India","journal":"Br J Haematol","issue":"2024 Jan 14. doi: 10.1111\/bjh.19277. Online ahead of print.","author":"Bharadwaj N, Munireddy J, Selvam S, Bharadwaj V, Prakash A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38220217"},{"title01":"Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR","title02":"Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR","journal":"Leukemia","issue":"2024 Jan 23. doi: 10.1038\/s41375-024-02148-3. Online ahead of print.","author":"Klyuchnikov E, Badbaran A, Massoud R, Freiberger P, Wolschke C, Ayuk F, Fehse B, Bacher U, Kr\u00f6ger N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263432"},{"title01":"Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts","title02":"Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts","journal":"Leukemia","issue":"2024 Jan 23. doi: 10.1038\/s41375-024-02143-8. Online ahead of print.","author":"Appelbaum JS, Wei AH, Mandrekar SJ, Tiong IS, Chua CC, Teh TC, Fong CY, Ting SB, Weber D, Benner A, Hill H, Saadati M, Yin J, Stone RM, Garcia-Manero G, Erba HP, Uy GL, Marcucci G, Larson RA, Thomas A, Freeman SD, Almuina NM, D\u00f6hner K, Thomas I, Russel NH, D\u00f6hner H, Othus M, Estey EH, Walter RB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263433"},{"title01":"Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment","title02":"Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment","journal":"Leukemia","issue":"2024 Jan 11. doi: 10.1038\/s41375-023-02127-0. Online ahead of print.","author":"H\u00e4nel G, Sch\u00f6nle A, Neumann AS, Nixdorf D, Philipp N, Sponheimer M, Leutbecher A, Emhardt AJ, Magno G, B\u00fccklein V, Eckmann J, Dunshee D, Kramar V, Korfi K, Colombetti S, Uma\u00f1a P, Klein C, Subklewe M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38212534"},{"title01":"How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies","title02":"How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies","journal":"Leukemia","issue":"2024 Jan 13. doi: 10.1038\/s41375-024-02139-4. Online ahead of print.","author":"Hehlmann R, Lauseker M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38218735"},{"title01":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","title02":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","journal":"Leukemia","issue":"2024 Jan 16. doi: 10.1038\/s41375-024-02136-7. Online ahead of print.","author":"Chen DW, Fan JM, Schrey JM, Mitchell DV, Jung SK, Hurwitz SN, Perez EB, Muraro MJ, Carroll M, Taylor DM, Kurre P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38228679"},{"title01":"Clonal medicine targeting DNA damage response eradicates leukemia","title02":"Clonal medicine targeting DNA damage response eradicates leukemia","journal":"Leukemia","issue":"2024 Jan 16. doi: 10.1038\/s41375-024-02138-5. Online ahead of print.","author":"Toma MM, Karami A, Nieborowska-Skorska M, Chirtala KN, Pepek M, Hadzijusufovic E, Stoklosa T, Valent P, Skorski T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38228681"},{"title01":"CApSiZing T-cell acute lymphoblastic leukemia","title02":"CApSiZing T-cell acute lymphoblastic leukemia","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.284714. Online ahead of print.","author":"Mandleywala K, Herranz D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235506"},{"title01":"Pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China","title02":"Pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.284228. Online ahead of print.","author":"Gong X, Fang Q, Gu R, Qiu S, Liu K, Lin D, Zhou C, Zhang G, Gong B, Liu Y, Li Y, Liu B, Wang Y, Wei H, Mi Y, Wang J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235508"},{"title01":"Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study","title02":"Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study","journal":"Br J Haematol","issue":"2024 Jan 18. doi: 10.1111\/bjh.19292. Online ahead of print.","author":"Miyashita N, Onozawa M, Matsukawa T, Mori A, Hidaka D, Minauchi K, Shigematsu A, Hashiguchi J, Igarashi T, Kakinoki Y, Tsutsumi Y, Ibata M, Wakasa K, Fujimoto K, Ishihara T, Sakai H, Iyama S, Oyake T, Kondo T, Teshima T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38238885"},{"title01":"Therapy with hypomethlyating agents\/venetoclax in patients with newly diagnosed acute myeloid leukaemia requiring admission to the intensive care unit: Possible reduction in side effects with preserved efficacy","title02":"Therapy with hypomethlyating agents\/venetoclax in patients with newly diagnosed acute myeloid leukaemia requiring admission to the intensive care unit: Possible reduction in side effects with preserved efficacy","journal":"Br J Haematol","issue":"2024 Jan 16. doi: 10.1111\/bjh.19311. Online ahead of print.","author":"Fiedler W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38228122"},{"title01":"\u03b1\u03b2T\/CD19-depleted haploHSCT for pediatric leukemia","title02":"\u03b1\u03b2T\/CD19-depleted haploHSCT for pediatric leukemia","journal":"Blood","issue":"2024 Jan 18;143(3):291.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38236610"},{"title01":"Plasmablastic lymphoma: better refine prognosis","title02":"Plasmablastic lymphoma: better refine prognosis","journal":"Blood","issue":"2024 Jan 11;143(2):101-102.","author":"Coppo P, Ricard L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38206643"},{"title01":"Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B cell lymphoma","title02":"Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B cell lymphoma","journal":"Blood","issue":"2024 Jan 11:blood.2023021002. doi: 10.1182\/blood.2023021002. Online ahead of print.","author":"Cerchietti L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38211334"},{"title01":"Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma","title02":"Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma","journal":"N Engl J Med","issue":"2024 Jan 25;390(4):368-369.","author":"Stadtmauer EA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265649"},{"title01":"Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma","title02":"Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma","journal":"Haematologica","issue":"2024 Jan 25. doi: 10.3324\/haematol.2023.284286. Online ahead of print.","author":"Agarwal G, Moore S, Sadler R, Varghese S, Turner A, Chen LY, Larham J, Gray N, Carty O, Barrett J, Koshiaris C, Kothari J, Bowcock S, Oppermann U, Gamble V, Cook G, Kyriakou C, Drayson M, Basu S, McDonald S, McKinley S, Gooding S, Javaid MK, Ramasamy K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38268439"},{"title01":"Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and\/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018\/AMN002 study","title02":"Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and\/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018\/AMN002 study","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.284238. Online ahead of print.","author":"Ninkovic S, Harrison SJ, Lee JJ, Murphy N, Lee JH, Estell J, Chen VM, Horvath N, Kim K, Eek R, Augustson B, Bang SM, Huang SY, Rajagopal R, Szabo F, Engeler D, Butcher BE, Mollee P, Durie B, Chng WJ, Quach H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235519"},{"title01":"Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma","title02":"Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma","journal":"Br J Haematol","issue":"2024 Jan 21. doi: 10.1111\/bjh.19275. Online ahead of print.","author":"Zhu H, Liu J, Gu J, Chen M, Kuang L, Huang B, Zou W, Li J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38246862"},{"title01":"Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study","title02":"Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study","journal":"Br J Haematol","issue":"2024 Jan 23. doi: 10.1111\/bjh.19302. Online ahead of print.","author":"Dima D, Rashid A, Davis JA, Shune L, Abdallah AO, Li H, DeJarnette S, Khouri J, Williams L, Hashmi H, Raza S, McGuirk J, Anwer F, Ahmed N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263627"},{"title01":"Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma","title02":"Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma","journal":"N Engl J Med","issue":"2024 Jan 25;390(4):368-369.","author":"Stadtmauer EA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265649"},{"title01":"Liver Transplantation","title02":"Liver Transplantation","journal":"N Engl J Med","issue":"2024 Jan 25;390(4):387.","author":"Kappe NN, Stolk J, van Hoek B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265663"},{"title01":"Liver Transplantation. Reply","title02":"Liver Transplantation. Reply","journal":"N Engl J Med","issue":"2024 Jan 25;390(4):387.","author":"Lucey MR, Furuya KN, Foley DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265664"},{"title01":"Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR","title02":"Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR","journal":"Leukemia","issue":"2024 Jan 23. doi: 10.1038\/s41375-024-02148-3. Online ahead of print.","author":"Klyuchnikov E, Badbaran A, Massoud R, Freiberger P, Wolschke C, Ayuk F, Fehse B, Bacher U, Kr\u00f6ger N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263432"},{"title01":"Machine perfusion in liver transplantation: still a long way off","title02":"Machine perfusion in liver transplantation: still a long way off","journal":"Lancet","issue":"2024 Jan 15:S0140-6736(23)02506-0. doi: 10.1016\/S0140-6736(23)02506-0. Online ahead of print.","author":"Dong J, Kuang X, Liao J, Gao J, Sun X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38237624"},{"title01":"Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma","title02":"Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma","journal":"J Clin Oncol","issue":"2024 Jan 22:JCO2301498. doi: 10.1200\/JCO.23.01498. Online ahead of print.","author":"Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38252908"},{"title01":"Nivolumab + Tacrolimus + Prednisone \u00b1 Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers","title02":"Nivolumab + Tacrolimus + Prednisone \u00b1 Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers","journal":"J Clin Oncol","issue":"2024 Jan 22:JCO2301497. doi: 10.1200\/JCO.23.01497. Online ahead of print.","author":"Schenk KM, Deutsch JS, Chandra S, Davar D, Eroglu Z, Khushalani NI, Luke JJ, Ott PA, Sosman JA, Aggarwal V, Schollenberger MD, Sharfman WH, Bibee KP, Scott JF, Loss MJ, Wang H, Qi H, Sharon E, Streicher H, Chen HX, Woodward RN, Bagnasco SM, Taube JM, Topalian SL, Brennan DC, Lipson EJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38252910"},{"title01":"Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation","title02":"Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation","journal":"J Clin Oncol","issue":"2024 Jan 17:JCO2301159. doi: 10.1200\/JCO.23.01159. Online ahead of print.","author":"Tobiasson M, Pandzic T, Illman J, Nilsson L, Westr\u00f6m S, Ejerblad E, Olesen G, Bj\u00f6rklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundstr\u00f6m L, von Bahr L, Baltzer-Sollander K, J\u00e4dersten M, Kyt\u00f6l\u00e4 S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SEW, Ebeling F, Cavelier L, Smidstrup Friis L, Dybedal I, Hellstr\u00f6m-Lindberg E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38232336"},{"title01":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","title02":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","journal":"Haematologica","issue":"2024 Jan 18. doi: 10.3324\/haematol.2023.284704. Online ahead of print.","author":"Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38235513"},{"title01":"Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma","title02":"Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma","journal":"Br J Haematol","issue":"2024 Jan 21. doi: 10.1111\/bjh.19275. Online ahead of print.","author":"Zhu H, Liu J, Gu J, Chen M, Kuang L, Huang B, Zou W, Li J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38246862"},{"title01":"Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report","title02":"Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report","journal":"Br J Haematol","issue":"2024 Jan 11. doi: 10.1111\/bjh.19289. Online ahead of print.","author":"Kunvarjee B, Contreras Yametti GP, Blouin AG, Linder GE, Borge PD, Maryamchik E, Budhai A, Gupta GK, Scaradavou A, Spitzer BG, Curran KJ, Oved JH, Harris AC, Sharma A, Boelens JJ, Cancio MI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38212144"},{"title01":"Id3 keeps the PD-1 checkpoint in check in GVHD","title02":"Id3 keeps the PD-1 checkpoint in check in GVHD","journal":"Blood","issue":"2024 Jan 11;143(2):103-104.","author":"Bernardi C, Simonetta F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38206642"},{"title01":"A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults","title02":"A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults","journal":"Blood","issue":"2024 Jan 16:blood.2023022865. doi: 10.1182\/blood.2023022865. Online ahead of print.","author":"Khandelwal P, Langenberg L, Luebbering N, Lake K, Butcher A, Werling K, Ramos KN, Taggart C, Choe HK, Vasu S, Teusink-Cross A, Koo J, Wallace G, Romick-Rosendale L, Watanabe-Chailland M, Haslam DB, Lane A, Davies SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38227933"},{"title01":"Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis","title02":"Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis","journal":"Leukemia","issue":"2024 Jan 19. doi: 10.1038\/s41375-024-02149-2. Online ahead of print.","author":"Eldeeb M, Konturek-Ciesla A, Zhang Q, Kharazi S, Tingvall-Gustafsson J, Ungerb\u00e4ck J, Sigvardsson M, Bryder D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38243088"},{"title01":"Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR","title02":"Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR","journal":"Leukemia","issue":"2024 Jan 23. doi: 10.1038\/s41375-024-02148-3. Online ahead of print.","author":"Klyuchnikov E, Badbaran A, Massoud R, Freiberger P, Wolschke C, Ayuk F, Fehse B, Bacher U, Kr\u00f6ger N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38263432"},{"title01":"Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols","title02":"Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols","journal":"Leukemia","issue":"2024 Jan 5. doi: 10.1038\/s41375-023-02115-4. Online ahead of print.","author":"Valtis YK, Flamand Y, Shimony S, Place AE, Silverman LB, Vrooman LM, Brunner AM, Sallan SE, Wadleigh M, Stone RM, DeAngelo DJ, Luskin MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38177437"},{"title01":"Harnessing upregulated E-selectin while enhancing SDF-1\u03b1 sensing redirects infused NK cells to the AML-perturbed bone marrow","title02":"Harnessing upregulated E-selectin while enhancing SDF-1\u03b1 sensing redirects infused NK cells to the AML-perturbed bone marrow","journal":"Leukemia","issue":"2024 Jan 5. doi: 10.1038\/s41375-023-02126-1. Online ahead of print.","author":"Sanz-Ortega L, Andersson A, Carlsten M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38182818"},{"title01":"FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia","title02":"FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia","journal":"Leukemia","issue":"2024 Jan 5. doi: 10.1038\/s41375-023-02131-4. Online ahead of print.","author":"Sung PJ, Selvam M, Riedel SS, Xie HM, Bryant K, Manning B, Wertheim GB, Kulej K, Pham L, Bowman RL, Peresie J, Nemeth MJ, Levine RL, Garcia BA, Meyer SE, Sidoli S, Bernt KM, Carroll M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38182819"},{"title01":"Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial","title02":"Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial","journal":"Haematologica","issue":"2024 Jan 4. doi: 10.3324\/haematol.2023.284409. Online ahead of print.","author":"Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, Van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Sim\u00f3n A, Sirvent FJB, Diaz-de-Heredia C, Rives S, Zwaan CM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186333"},{"title01":"The first human acute myeloid leukemia genome ever fully sequenced","title02":"The first human acute myeloid leukemia genome ever fully sequenced","journal":"Haematologica","issue":"2024 Jan 1;109(1):1-2.","author":"Falini B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186342"},{"title01":"Acute myeloid leukemia driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias","title02":"Acute myeloid leukemia driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias","journal":"Haematologica","issue":"2024 Jan 4. doi: 10.3324\/haematol.2023.283944. Online ahead of print.","author":"Fowler-Shorten DJ, Maynard RS, Hampton K, Altera A, Markham M, Ehikioya M, Wojtowicz EE, Bowles KM, Rushworth SA, Hellmich C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186347"},{"title01":"Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin","title02":"Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin","journal":"Haematologica","issue":"2024 Jan 4. doi: 10.3324\/haematol.2023.284318. Online ahead of print.","author":"Genoud V, Dutoit V, Thang NT, Janowczyk A, McKee T, Chalandon Y, Tsantoulis P, Dietrich PY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186348"},{"title01":"The role of the mineralocorticoid receptor in steroid-induced cytotoxicity in pediatric acute lymphoblastic leukemia","title02":"The role of the mineralocorticoid receptor in steroid-induced cytotoxicity in pediatric acute lymphoblastic leukemia","journal":"Haematologica","issue":"2024 Jan 11. doi: 10.3324\/haematol.2023.282928. Online ahead of print.","author":"Van Hulst AM, Van der Zwet JCG, Buijs-Gladdines JGCAM, Smits WK, Fiocco M, Pieters R, Van Leeuwen FN, Van den Heuvel-Eibrink MM, Van den Akker ELT, Meijerink JPP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38205521"},{"title01":"Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT","title02":"Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT","journal":"Haematologica","issue":"2024 Jan 11. doi: 10.3324\/haematol.2023.284359. Online ahead of print.","author":"Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Ya\u00f1ez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poir\u00e9 X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O, McLornan DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38205539"},{"title01":"Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia","title02":"Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia","journal":"Br J Haematol","issue":"2024 Jan 5. doi: 10.1111\/bjh.19291. Online ahead of print.","author":"Liang P, Xie Y, Liu Z, Wang D, Li Q, Lu Y, Xue S, Wang Y, Chen S, Wu D, Fu J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38180132"},{"title01":"Tri-ing to decipher trisomy AML","title02":"Tri-ing to decipher trisomy AML","journal":"Br J Haematol","issue":"2024 Jan 8. doi: 10.1111\/bjh.19294. Online ahead of print.","author":"Shimony S, Chen EC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38190804"},{"title01":"Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia","title02":"Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia","journal":"Br J Haematol","issue":"2024 Jan 10. doi: 10.1111\/bjh.19297. Online ahead of print.","author":"Loh Z, Ashby M, Van Veldhuizen E, Li W, Chee A, Aung W, Lavrukhina Y, Mason G, Pelly T, Nedumannil R, Kosciejew S, Mokoonlall M, Lim J, Calov G, Butler L, Hillebrand P, Beekman A, Rathnasekara GK, Raj S, Zhang C, Yao Y, Iland H, Grigg A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38198799"},{"title01":"Mortality trends of chronic lymphocytic leukaemia in the United States with the emergence of targeted therapy","title02":"Mortality trends of chronic lymphocytic leukaemia in the United States with the emergence of targeted therapy","journal":"Br J Haematol","issue":"2023 Dec 28. doi: 10.1111\/bjh.19276. Online ahead of print.","author":"Tan JY, Yeo YH, Tan MC, Chavez JC, Chisti MM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38155366"},{"title01":"Ibrutinib reversal of immune exhaustion in CLL","title02":"Ibrutinib reversal of immune exhaustion in CLL","journal":"Blood","issue":"2024 Jan 4;143(1):5-7.","author":"Moss P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38175677"},{"title01":"Arterio-Occlusive Events Among Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors","title02":"Arterio-Occlusive Events Among Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors","journal":"Blood","issue":"2024 Jan 9:blood.2023022403. doi: 10.1182\/blood.2023022403. Online ahead of print.","author":"Veltmaat L, Cortes J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194683"},{"title01":"The remission status of AML patients post alloSCT is associated with a distinct single-cell bone marrow T cell signature","title02":"The remission status of AML patients post alloSCT is associated with a distinct single-cell bone marrow T cell signature","journal":"Blood","issue":"2024 Jan 9:blood.2023021815. doi: 10.1182\/blood.2023021815. Online ahead of print.","author":"Mathioudaki A, Wang X, Sedloev DN, Huth R, Kamal A, Hundemer M, Liu Y, Vasileiou S, Lulla PD, M\u00fcller-Tidow C, Dreger P, Luft T, Sauer T, Schmitt M, Zaugg JB, Pabst C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38197505"},{"title01":"CBFB::MYH11 fusion in a nonmonocytic acute myeloid leukemia","title02":"CBFB::MYH11<\/i> fusion in a nonmonocytic acute myeloid leukemia","journal":"Blood","issue":"2023 Dec 28;142(26):2332.","author":"Quessada J, Loosveld M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38153768"},{"title01":"Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential","title02":"Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential","journal":"Leukemia","issue":"2024 Jan 6. doi: 10.1038\/s41375-023-02134-1. Online ahead of print.","author":"Zhang C, Stelloo E, Barrans S, Cucco F, Jiang D, Tzioni MM, Chen Z, Li Y, Swennenhuis JF, Makker J, R\u00e1s\u00f3-Barnett L, Liu H, El-Daly H, Soilleux E, Shah N, Nagumantry SK, Kyaw M, Prahladan MP, Tooze R, Westhead DR, Feitsma H, Davies AJ, Burton C, Johnson PWM, Du MQ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38184753"},{"title01":"Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma","title02":"Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma","journal":"Leukemia","issue":"2024 Jan 9. doi: 10.1038\/s41375-023-02130-5. Online ahead of print.","author":"Liu B, Zhao X, Zhang S, Li Q, Li X, Huang D, Xia J, Ma N, Duan Y, Zhang X, Rao J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38195819"},{"title01":"Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis","title02":"Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis","journal":"Leukemia","issue":"2023 Dec 29. doi: 10.1038\/s41375-023-02120-7. Online ahead of print.","author":"Ren W, Wan H, Own SA, Berglund M, Wang X, Yang M, Li X, Liu D, Ye X, Sonnevi K, Enblad G, Amini RM, Sander B, Wu K, Zhang H, Wahlin BE, Smedby KE, Pan-Hammarstr\u00f6m Q.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38158444"},{"title01":"Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b\/2 study","title02":"Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b\/2 study","journal":"Lancet Haematol","issue":"2024 Jan 5:S2352-3026(23)00345-9. doi: 10.1016\/S2352-3026(23)00345-9. Online ahead of print.","author":"Abrisqueta P, Gonz\u00e1lez-Barca E, Panizo C, P\u00e9rez JMA, Miall F, Bastos-Oreiro M, Triguero A, Banerjee L, McMillan A, Seymour E, Hirata J, de Guzman J, Sharma S, Jin HY, Musick L, Diefenbach C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38190832"},{"title01":"Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma","title02":"Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma","journal":"J Clin Oncol","issue":"2024 Jan 9:JCO2301912. doi: 10.1200\/JCO.23.01912. Online ahead of print.","author":"Kahl BS, Jegede OA, Peterson C, Swinnen LJ, Habermann TM, Schuster SJ, Weiss M, Fishkin PA, Fenske TS, Williams ME.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194625"},{"title01":"Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas","title02":"Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas","journal":"Br J Haematol","issue":"2024 Jan 4. doi: 10.1111\/bjh.19280. Online ahead of print.","author":"Fardella E, Zanirato G, Magni M, Caldarelli N, Chiappella A, Dodero A, Ljevar S, Orsucci L, Re A, Usai SV, Stefoni V, Castellino C, Rossi FG, Pinto A, Carniti C, Corradini P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38176400"},{"title01":"Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow","title02":"Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow","journal":"Br J Haematol","issue":"2024 Jan 7. doi: 10.1111\/bjh.19283. Online ahead of print.","author":"Liapis K, Misidou C, Spanoudakis E, Kotsianidis I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38185474"},{"title01":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study","title02":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study","journal":"Br J Haematol","issue":"2023 Dec 28. doi: 10.1111\/bjh.19272. Online ahead of print.","author":"Baech J, Husby S, Trab T, Kragholm K, Brown P, G\u00f8rl\u00f8v JS, J\u00f8rgensen JM, Gudbrandsdottir S, Severinsen MT, Gr\u00f8nbaek K, Larsen TS, W\u00e4sterlid T, Eloranta S, Smeland KB, Jakobsen LH, El-Galaly TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38155503"},{"title01":"Epstein-Barr virus-associated lymphomas decoded","title02":"Epstein-Barr virus-associated lymphomas decoded","journal":"Br J Haematol","issue":"2023 Dec 28. doi: 10.1111\/bjh.19255. Online ahead of print.","author":"Bednarska K, Chowdhury R, Tobin JWD, Swain F, Keane C, Boyle S, Khanna R, Gandhi MK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38155519"},{"title01":"The follicular lymphoma tumor microenvironment at single cell and spatial resolution","title02":"The follicular lymphoma tumor microenvironment at single cell and spatial resolution","journal":"Blood","issue":"2024 Jan 9:blood.2023020999. doi: 10.1182\/blood.2023020999. Online ahead of print.","author":"Radtke A, Roschewski M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194685"},{"title01":"Durable Response After Tisagenlecleucel in Adults With Relapsed\/Refractory Follicular Lymphoma: ELARA Trial Update","title02":"Durable Response After Tisagenlecleucel in Adults With Relapsed\/Refractory Follicular Lymphoma: ELARA Trial Update","journal":"Blood","issue":"2024 Jan 9:blood.2023021567. doi: 10.1182\/blood.2023021567. Online ahead of print.","author":"Dreyling M, Fowler NH, Dickinson M, Mart\u00ednez-L\u00f3pez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis CB, Riedell PA, Ho PJ, Perez-Simon JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJ, Teshima T, Patten PE, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Paule I, Zia A, Awasthi R, Han X, Germano D, O'Donovan DS, Ramos RJ, Maier HJ, Masood A, Thieblemont C, Schuster SJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194692"},{"title01":"Tribulations of trials in aggressive lymphoma","title02":"Tribulations of trials in aggressive lymphoma","journal":"Blood","issue":"2023 Dec 28;142(26):2232-2234.","author":"Barraclough A, Hawkes EA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38153771"},{"title01":"Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed\/refractory myeloma","title02":"Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed\/refractory myeloma","journal":"Leukemia","issue":"2024 Jan 6. doi: 10.1038\/s41375-023-02129-y. Online ahead of print.","author":"Fischer L, Grieb N, Born P, Weiss R, Seiffert S, Boldt A, Fricke S, Franz P, Heyn S, Kubasch AS, Baber R, Weidner H, Wang SY, Bach E, Hoffmann S, Ussmann J, Kirchberg J, Hell S, Schwind S, Metzeler KH, Herling M, Jentzsch M, Franke GN, Sack U, Reiche K, K\u00f6hl U, Platzbecker U, Vucinic V, Merz M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38184754"},{"title01":"Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study","title02":"Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study","journal":"Leukemia","issue":"2023 Dec 29. doi: 10.1038\/s41375-023-02132-3. Online ahead of print.","author":"Castro F, Parikh R, Eustaquio JC, Derkach A, Joseph JM, Lesokhin AM, Usmani SZ, Shah UA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38158443"},{"title01":"Genomic Classification and Individualized Prognosis in Multiple Myeloma","title02":"Genomic Classification and Individualized Prognosis in Multiple Myeloma","journal":"J Clin Oncol","issue":"2024 Jan 9:JCO2301277. doi: 10.1200\/JCO.23.01277. Online ahead of print.","author":"Maura F, Rajanna AR, Ziccheddu B, Poos AM, Derkach A, Maclachlan K, Durante M, Diamond B, Papadimitriou M, Davies F, Boyle EM, Walker B, Hultcrantz M, Silva A, Hampton O, Teer JK, Siegel EM, Bolli N, Jackson GH, Kaiser M, Pawlyn C, Cook G, Kazandjian D, Stein C, Chesi M, Bergsagel L, Mai EK, Goldschmidt H, Weisel KC, Fenk R, Raab MS, Van Rhee F, Usmani S, Shain KH, Weinhold N, Morgan G, Landgren O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194610"},{"title01":"Elucidation of molecular basis of osteolytic bone lesions in advanced multiple myeloma","title02":"Elucidation of molecular basis of osteolytic bone lesions in advanced multiple myeloma","journal":"Haematologica","issue":"2024 Jan 11. doi: 10.3324\/haematol.2023.283784. Online ahead of print.","author":"Shin D, Kim MJ, Chun S, Kim D, Lee C, Ahn KS, Jung E, Kim D, Lee BC, Hwang D, Kim Y, Yoon SS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38205555"},{"title01":"Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma","title02":"Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2024 Jan 4. doi: 10.1111\/bjh.19281. Online ahead of print.","author":"Hagen P, Norton J, Tsai S, Campo L, Lee M, Gomez K, Stiff P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38176404"},{"title01":"Early detection of multiple myeloma: A first step towards a screening programme","title02":"Early detection of multiple myeloma: A first step towards a screening programme","journal":"Br J Haematol","issue":"2024 Jan 2. doi: 10.1111\/bjh.19274. Online ahead of print.","author":"Scheid C, Landgren O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38168005"},{"title01":"Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services","title02":"Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services","journal":"Br J Haematol","issue":"2024 Jan 2. doi: 10.1111\/bjh.19224. Online ahead of print.","author":"Drayson M, Jennis T, Laketic-Ljubojevic I, Patel D, Pratt G, Renwick S, Richter A, Wheeler R, Sheldon J, Sadler R, Stapleton M, Willis F, Whiston M; for Myeloma UK working group for laboratory best practice.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38168756"},{"title01":"Venetoclax in myeloma: to B, or not to B","title02":"Venetoclax in myeloma: to B, or not to B","journal":"Blood","issue":"2024 Jan 4;143(1):4-5.","author":"Raab MS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38175678"},{"title01":"BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: Efficacy, safety and resistance mechanisms","title02":"BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: Efficacy, safety and resistance mechanisms","journal":"Blood","issue":"2024 Jan 9:blood.2023022499. doi: 10.1182\/blood.2023022499. Online ahead of print.","author":"Lee H, Neri P, Bahlis NJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194680"},{"title01":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","title02":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","journal":"Lancet Haematol","issue":"2024 Jan 3:S2352-3026(23)00342-3. doi: 10.1016\/S2352-3026(23)00342-3. Online ahead of print.","author":"Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte RF, Giebel S, Greinix H, Hazenberg MD, Kr\u00f6ger N, Mielke S, Mohty M, Nagler A, Passweg J, Patriarca F, Ruutu T, Schoemans H, Solano C, Vrhovac R, Wolff D, Zeiser R, Sureda A, Peric Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38184001"},{"title01":"Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient","title02":"Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient","journal":"Lancet","issue":"2024 Jan 6;403(10421):e1.","author":"Kearney N, Stefanovic N, Roche M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38184337"},{"title01":"Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study","title02":"Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study","journal":"Haematologica","issue":"2024 Jan 4. doi: 10.3324\/haematol.2023.284445. Online ahead of print.","author":"Ruggeri A, Santoro N, Galimard JE, Kalwak K, Algeri M, Zubarovskaya L, Czyzewski K, Skorobogatova E, Sedlacek P, Besley C, Balduzzi A, Bertrand Y, Peristeri J, Fagioli F, Ifversen M, Gozdzik J, Peters C, Versluijs B, Biffi A, Prete A, Faraci M, Ghemlas I, Bodova I, Aleinikova O, Dalissier A, Rocha V, Corbacioglu S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186346"},{"title01":"Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT","title02":"Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT","journal":"Haematologica","issue":"2024 Jan 11. doi: 10.3324\/haematol.2023.284359. Online ahead of print.","author":"Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Ya\u00f1ez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poir\u00e9 X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O, McLornan DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38205539"},{"title01":"Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma","title02":"Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2024 Jan 4. doi: 10.1111\/bjh.19281. Online ahead of print.","author":"Hagen P, Norton J, Tsai S, Campo L, Lee M, Gomez K, Stiff P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38176404"},{"title01":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study","title02":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study","journal":"Br J Haematol","issue":"2023 Dec 28. doi: 10.1111\/bjh.19272. Online ahead of print.","author":"Baech J, Husby S, Trab T, Kragholm K, Brown P, G\u00f8rl\u00f8v JS, J\u00f8rgensen JM, Gudbrandsdottir S, Severinsen MT, Gr\u00f8nbaek K, Larsen TS, W\u00e4sterlid T, Eloranta S, Smeland KB, Jakobsen LH, El-Galaly TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38155503"},{"title01":"Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation","title02":"Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Jan 2. doi: 10.1111\/bjh.19282. Online ahead of print.","author":"Jiang Z, Fan Z, Zhang T, Lin R, Xu H, Xu N, Huang F, Chi P, Ou X, Wang Z, Liu H, Zhao K, Jiang L, Yu S, Sun J, Liu Q, Xuan L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38168845"},{"title01":"CD24Fc to DAMPen GVHD","title02":"CD24Fc to DAMPen GVHD","journal":"Blood","issue":"2024 Jan 4;143(1):1-2.","author":"Martin PJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38175676"},{"title01":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","title02":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","journal":"Lancet Haematol","issue":"2024 Jan 3:S2352-3026(23)00342-3. doi: 10.1016\/S2352-3026(23)00342-3. Online ahead of print.","author":"Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte RF, Giebel S, Greinix H, Hazenberg MD, Kr\u00f6ger N, Mielke S, Mohty M, Nagler A, Passweg J, Patriarca F, Ruutu T, Schoemans H, Solano C, Vrhovac R, Wolff D, Zeiser R, Sureda A, Peric Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38184001"},{"title01":"Acute myeloid leukemia driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias","title02":"Acute myeloid leukemia driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias","journal":"Haematologica","issue":"2024 Jan 4. doi: 10.3324\/haematol.2023.283944. Online ahead of print.","author":"Fowler-Shorten DJ, Maynard RS, Hampton K, Altera A, Markham M, Ehikioya M, Wojtowicz EE, Bowles KM, Rushworth SA, Hellmich C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186347"},{"title01":"Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT","title02":"Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT","journal":"Haematologica","issue":"2024 Jan 11. doi: 10.3324\/haematol.2023.284359. Online ahead of print.","author":"Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Ya\u00f1ez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poir\u00e9 X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O, McLornan DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38205539"},{"title01":"Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma","title02":"Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2024 Jan 4. doi: 10.1111\/bjh.19281. Online ahead of print.","author":"Hagen P, Norton J, Tsai S, Campo L, Lee M, Gomez K, Stiff P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38176404"},{"title01":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study","title02":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study","journal":"Br J Haematol","issue":"2023 Dec 28. doi: 10.1111\/bjh.19272. Online ahead of print.","author":"Baech J, Husby S, Trab T, Kragholm K, Brown P, G\u00f8rl\u00f8v JS, J\u00f8rgensen JM, Gudbrandsdottir S, Severinsen MT, Gr\u00f8nbaek K, Larsen TS, W\u00e4sterlid T, Eloranta S, Smeland KB, Jakobsen LH, El-Galaly TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38155503"},{"title01":"Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation","title02":"Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Jan 2. doi: 10.1111\/bjh.19282. Online ahead of print.","author":"Jiang Z, Fan Z, Zhang T, Lin R, Xu H, Xu N, Huang F, Chi P, Ou X, Wang Z, Liu H, Zhao K, Jiang L, Yu S, Sun J, Liu Q, Xuan L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38168845"},{"title01":"EBV-infected hematopoietic stem cells drive CAEBV","title02":"EBV-infected hematopoietic stem cells drive CAEBV","journal":"Blood","issue":"2024 Jan 4;143(1):2-4.","author":"Khanna R, Gandhi MK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38175680"},{"title01":"Hydroxyurea reduces infections in children with sickle cell anemia in Uganda","title02":"Hydroxyurea reduces infections in children with sickle cell anemia in Uganda","journal":"Blood","issue":"2024 Jan 3:blood.2023021575. doi: 10.1182\/blood.2023021575. Online ahead of print.","author":"Namazzi R, Bond C, Conroy A, Datta D, Tagoola A, Goings MJ, Jang JH, Ware RE, Opoka RO, John CC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38169476"},{"title01":"B-cell responses to ITP treatments","title02":"B-cell responses to ITP treatments","journal":"Br J Haematol","issue":"2023 Dec 28. doi: 10.1111\/bjh.19199. Online ahead of print.","author":"Crickx E, Mah\u00e9vas M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38155442"},{"title01":"Gene regulation in t(6;9) DEK::NUP214 Acute Myeloid Leukemia resembles that of FLT3-ITD\/NPM1 Acute Myeloid Leukemia but with an altered HOX\/MEIS axis","title02":"Gene regulation in t(6;9) DEK::NUP214 Acute Myeloid Leukemia resembles that of FLT3-ITD\/NPM1 Acute Myeloid Leukemia but with an altered HOX\/MEIS axis","journal":"Leukemia","issue":"2024 Jan 4. doi: 10.1038\/s41375-023-02118-1. Online ahead of print.","author":"Potluri S, Kellaway SG, Coleman DJL, Keane P, Imperato MR, Assi SA, Cockerill PN, Bonifer C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38172329"},{"title01":"Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study","title02":"Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study","journal":"Haematologica","issue":"2024 Jan 4. doi: 10.3324\/haematol.2023.284445. Online ahead of print.","author":"Ruggeri A, Santoro N, Galimard JE, Kalwak K, Algeri M, Zubarovskaya L, Czyzewski K, Skorobogatova E, Sedlacek P, Besley C, Balduzzi A, Bertrand Y, Peristeri J, Fagioli F, Ifversen M, Gozdzik J, Peters C, Versluijs B, Biffi A, Prete A, Faraci M, Ghemlas I, Bodova I, Aleinikova O, Dalissier A, Rocha V, Corbacioglu S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38186346"},{"title01":"The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib","title02":"The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib","journal":"Leukemia","issue":"2023 Dec 21. doi: 10.1038\/s41375-023-02109-2. Online ahead of print.","author":"Machova Polakova K, Albeer A, Polivkova V, Krutska M, Vlcanova K, Curik N, Fabarius A, Klamova H, Spiess B, Waller CF, Br\u00fcmmendorf TH, Dengler J, Kunzmann V, Burchert A, Belohlavkova P, Mustjoki S, Faber E, Mayer J, Zackova D, Panayiotidis P, Richter J, Hjorth-Hansen H, Kami\u0144ska M, P\u0142onka M, Szczepanek E, Szarejko M, Bober G, Hus I, Grzybowska-Izydorczyk O, Wasilewska E, Paczkowska E, Niesiob\u0119dzka-Kr\u0119\u017cel J, Giannopoulos K, Mahon FX, Sacha T, Sau\u00dfele S, Pfirrmann M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38129513"},{"title01":"Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission","title02":"Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission","journal":"Leukemia","issue":"2023 Dec 21. doi: 10.1038\/s41375-023-02119-0. Online ahead of print.","author":"Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, Doki N, Yoshihara S, Katayama Y, Eto T, Tanaka M, Takada S, Kawakita T, Nishida T, Ota S, Serizawa K, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Konuma T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38129514"},{"title01":"Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis","title02":"Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis","journal":"Leukemia","issue":"2023 Dec 22. doi: 10.1038\/s41375-023-02121-6. Online ahead of print.","author":"Lee KH, Lee S, Park YH, Mun YC, Choi EJ, Choi Y, Park HS, Lee JH, Lee JH, Park SY, Yoon SR, Choi I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135760"},{"title01":"Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia","title02":"Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia","journal":"Leukemia","issue":"2023 Dec 26. doi: 10.1038\/s41375-023-02117-2. Online ahead of print.","author":"Akiyama H, Zhao R, Ostermann LB, Li Z, Tcheng M, Yazdani SJ, Moayed A, Pryor ML 2nd, Slngh S, Baran N, Ayoub E, Nishida Y, Mak PY, Ruvolo VR, Carter BZ, Schimmer AD, Andreeff M, Ishizawa J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38148395"},{"title01":"DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5\/del(5q) AML","title02":"DELE1<\/i> haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5\/del(5q) AML","journal":"Leukemia","issue":"2023 Dec 15. doi: 10.1038\/s41375-023-02107-4. Online ahead of print.","author":"Spinella JF, Chagraoui J, Moison C, Lavall\u00e9e VP, Boivin I, Gracias D, Lavall\u00e9e S, Carpentier GR, Beliveau F, H\u00e9bert J, Sauvageau G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38102204"},{"title01":"Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed\/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms","title02":"Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed\/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms","journal":"Leukemia","issue":"2023 Dec 19. doi: 10.1038\/s41375-023-02110-9. Online ahead of print.","author":"Murphy T, Mason JM, Leber B, Bray MR, Chan SM, Gupta V, Khalaf D, Maze D, McNamara CJ, Schimmer AD, Schuh AC, Sibai H, Trus M, Valiquette D, Martin K, Nguyen L, Li X, Mak TW, Minden MD, Yee KWL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38114624"},{"title01":"Backtracking to the future: unraveling the origins of childhood leukemia","title02":"Backtracking to the future: unraveling the origins of childhood leukemia","journal":"Leukemia","issue":"2023 Dec 20. doi: 10.1038\/s41375-023-02111-8. Online ahead of print.","author":"de Smith AJ, Wiemels JL, Mead AJ, Roberts I, Roy A, Spector LG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38123697"},{"title01":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","title02":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","journal":"Lancet Haematol","issue":"2024 Jan;11(1):e12-e13.","author":"Chevallier P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135369"},{"title01":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","title02":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","journal":"Lancet Haematol","issue":"2024 Jan;11(1):e13-e14.","author":"Boissel N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135370"},{"title01":"Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study","title02":"Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study","journal":"Lancet Haematol","issue":"2024 Jan;11(1):e15-e26.","author":"Garcia-Manero G, McCloskey J, Griffiths EA, Yee KWL, Zeidan AM, Al-Kali A, Deeg HJ, Patel PA, Sabloff M, Keating MM, Zhu N, Gabrail NY, Fazal S, Maly J, Odenike O, Kantarjian H, DeZern AE, O'Connell CL, Roboz GJ, Busque L, Buckstein R, Amin H, Randhawa J, Leber B, Shastri A, Dao KH, Oganesian A, Hao Y, Keer HN, Azab M, Savona MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135371"},{"title01":"Changing the paradigm of AML care in India","title02":"Changing the paradigm of AML care in India","journal":"Lancet Haematol","issue":"2024 Jan;11(1):e9.","author":"Singh A, Jain A, Tabbassum H, Siraj F, Rishi B, Misra A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135376"},{"title01":"TLR3 agonism augments CD47 inhibition in acute myeloid leukemia","title02":"TLR3 agonism augments CD47 inhibition in acute myeloid leukemia","journal":"Haematologica","issue":"2023 Dec 28. doi: 10.3324\/haematol.2023.283850. Online ahead of print.","author":"Ramsey HE, Gorska AE, Smith BN, Monteith AJ, Fuller L, Arrate MP, Savona MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38152031"},{"title01":"LNK\/SH2B3 as a novel driver in juvenile myelomonocytic leukemia","title02":"LNK\/SH2B3<\/i> as a novel driver in juvenile myelomonocytic leukemia","journal":"Haematologica","issue":"2023 Dec 28. doi: 10.3324\/haematol.2023.283776. Online ahead of print.","author":"Wintering A, Hecht A, Meyer J, Wong EB, H\u00fcbner J, Abelson S, Feldman K, Kennedy VE, Peretz CAC, French DL, Maguire JA, Jobaliya C, Vasquez MR, Desai S, Dulman R, Nemecek E, Haines H, Hammad M, El Haddad A, Kogan SC, Abdullaev Z, Chehab FF, Tasian SK, Smith CC, Loh ML, Stieglitz E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38152053"},{"title01":"Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax\/azacitidine","title02":"Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax\/azacitidine","journal":"Haematologica","issue":"2023 Dec 14. doi: 10.3324\/haematol.2023.283790. Online ahead of print.","author":"Winters AC, Minhajuddin M, Stevens BM, Major A, Bosma G, Abbott D, Miltgen N, Yuan J, Treece AL, Siegele BJ, Ewalt MD, Gutman JA, Jordan CT, Pollyea DA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38105738"},{"title01":"ToTAL1y degraded – rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia","title02":"ToTAL1y degraded – rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia","journal":"Haematologica","issue":"2023 Dec 14. doi: 10.3324\/haematol.2023.284447. Online ahead of print.","author":"Costa JR, Mansour MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38105739"},{"title01":"Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy","title02":"Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy","journal":"Haematologica","issue":"2023 Dec 21. doi: 10.3324\/haematol.2023.284101. Online ahead of print.","author":"Cox WPJ, Evander N, Van Ingen Schenau DS, Stoll GR, Anderson N, De Groot L, Gr\u00fcnewald KJT, Hagelaar R, Butler M, Kuiper RP, Van der Meer LT, Van Leeuwen FN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38124624"},{"title01":"SEQ-ing the genetic constellation of acute lymphoblastic leukaemia","title02":"SEQ-ing the genetic constellation of acute lymphoblastic leukaemia","journal":"Haematologica","issue":"2023 Dec 21. doi: 10.3324\/haematol.2023.284456. Online ahead of print.","author":"Li Z, Yeoh AEJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38124627"},{"title01":"Home time among older adults with acute myeloid leukemia by therapy intensity","title02":"Home time among older adults with acute myeloid leukemia by therapy intensity","journal":"Haematologica","issue":"2023 Dec 21. doi: 10.3324\/haematol.2023.284133. Online ahead of print.","author":"Jensen CE, Deal AM, Wardell AC, Heiling HM, Beke KE, Richardson DR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38124658"},{"title01":"How to improve treatment-free remission eligibility in chronic myeloid leukaemia?","title02":"How to improve treatment-free remission eligibility in chronic myeloid leukaemia?","journal":"Br J Haematol","issue":"2023 Dec 26. doi: 10.1111\/bjh.19269. Online ahead of print.","author":"Costa A, Breccia M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38148564"},{"title01":"Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort","title02":"Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort","journal":"Br J Haematol","issue":"2023 Dec 14. doi: 10.1111\/bjh.19251. Online ahead of print.","author":"Roy Moulik N, Keerthivasagam S, Pandey A, Agiwale J, Hegde K, Chatterjee G, Dhamne C, Prasad M, Chichra A, Srinivasan S, Mohanty P, Jain H, Shetty D, Tembhare P, Patkar N, Narula G, Subramanian PG, Banavali S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38098201"},{"title01":"KMT2A-rearranged B-lymphoblastic leukemia\/lymphoma with surface light chain restriction and lacking immature markers","title02":"KMT2A<\/i>-rearranged B-lymphoblastic leukemia\/lymphoma with surface light chain restriction and lacking immature markers","journal":"Blood","issue":"2023 Dec 21;142(25):2220.","author":"Fu L, Gong S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38127411"},{"title01":"Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in Adult T-cell leukemia\/lymphoma","title02":"Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in Adult T-cell leukemia\/lymphoma","journal":"Blood","issue":"2023 Dec 24:blood.2023021423. doi: 10.1182\/blood.2023021423. Online ahead of print.","author":"Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, Hasegawa H, Maeda M, Teshima T, Yang Y, Nakagawa M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38142436"},{"title01":"PPM1D inhibition may allow us to WIP leukemia","title02":"PPM1D inhibition may allow us to WIP leukemia","journal":"Blood","issue":"2023 Dec 14;142(24):2040-2042.","author":"Marcellino BK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38095924"},{"title01":"Mezigdomide is effective alone and in combination with Menin inhibition in pre-clinical models of KMT2A-r and NPM1c AML","title02":"Mezigdomide is effective alone and in combination with Menin inhibition in pre-clinical models of KMT2A<\/i>-r and NPM1c<\/i> AML","journal":"Blood","issue":"2023 Dec 14:blood.2023021105. doi: 10.1182\/blood.2023021105. Online ahead of print.","author":"Bourgeois W, Cutler JA, Aubrey BJ, Wenge D, Perner F, Martucci C, Henrich JA, Klega K, Nowak RP, Donovan KA, Boileau M, Wen Y, Hatton C, Apazidis AA, Olsen SN, Kirmani N, Pikman Y, Pollard JA, Perry JA, Sperling AS, Ebert BL, McGeehan GM, Crompton BD, Fischer ES, Armstrong SA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38096371"},{"title01":"Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study","title02":"Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study","journal":"J Clin Oncol","issue":"2023 Dec 14:JCO2300838. doi: 10.1200\/JCO.23.00838. Online ahead of print.","author":"Pott C, Jurinovic V, Trotman J, Kehden B, Unterhalt M, Herold M, Jagt RV, Janssens A, Kneba M, Mayer J, Young M, Schmidt C, Knapp A, Nielsen T, Brown H, Spielewoy N, Harbron C, Bottos A, Mundt K, Marcus R, Hiddemann W, Hoster E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38096461"},{"title01":"Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study","title02":"Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study","journal":"J Clin Oncol","issue":"2023 Dec 18:JCO2301586. doi: 10.1200\/JCO.23.01586. Online ahead of print.","author":"Sarkozy C, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Damaj G, Gastinne T, Tessoulin B, Ribrag V, Casasnovas O, Haioun C, Houot R, Jardin F, Van Den Neste E, Cheminant M, Morschhauser F, Callanan M, Safar V, Gressin R, Hermine O, Le Gouill S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38109684"},{"title01":"Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed\/Refractory Hodgkin Lymphoma","title02":"Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed\/Refractory Hodgkin Lymphoma","journal":"J Clin Oncol","issue":"2023 Dec 19:JCO2301115. doi: 10.1200\/JCO.23.01115. Online ahead of print.","author":"Aoki T, Jiang A, Xu A, Yin Y, Gamboa A, Milne K, Takata K, Miyata-Takata T, Chung S, Rai S, Wu S, Warren M, Strong C, Goodyear T, Morris K, Chong LC, Hav M, Colombo AR, Telenius A, Boyle M, Ben-Neriah S, Power M, Gerrie AS, Weng AP, Karsan A, Roth A, Farinha P, Scott DW, Savage KJ, Nelson BH, Merchant A, Steidl C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38113419"},{"title01":"Huge right atrial mass in mantle cell lymphoma","title02":"Huge right atrial mass in mantle cell lymphoma","journal":"Br J Haematol","issue":"2023 Dec 21. doi: 10.1111\/bjh.19258. Online ahead of print.","author":"Totaro A, Calafiore AM, Sacra C, Magnano D, Gasbarrino C, Testa G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38126458"},{"title01":"Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma","title02":"Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma","journal":"Br J Haematol","issue":"2023 Dec 22. doi: 10.1111\/bjh.19266. Online ahead of print.","author":"Motomura Y, Yoshifuji K, Tachibana T, Takase H, Arai A, Tanaka K, Okada K, Nogami A, Umezawa Y, Sakashita C, Yamamoto M, Mori T, Nagao T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38131400"},{"title01":"A case of a large number of Reed-Sternberg cells in pleural fluid following treatment of classical Hodgkin lymphoma","title02":"A case of a large number of Reed-Sternberg cells in pleural fluid following treatment of classical Hodgkin lymphoma","journal":"Br J Haematol","issue":"2023 Dec 20. doi: 10.1111\/bjh.19260. Online ahead of print.","author":"Jin X, Zhou W, Jiang H, Chen Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38124512"},{"title01":"KMT2A-rearranged B-lymphoblastic leukemia\/lymphoma with surface light chain restriction and lacking immature markers","title02":"KMT2A<\/i>-rearranged B-lymphoblastic leukemia\/lymphoma with surface light chain restriction and lacking immature markers","journal":"Blood","issue":"2023 Dec 21;142(25):2220.","author":"Fu L, Gong S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38127411"},{"title01":"Peripheral T-cell lymphoma: Are all patients high-risk?","title02":"Peripheral T-cell lymphoma: Are all patients high-risk?","journal":"Blood","issue":"2023 Dec 24:blood.2023020912. doi: 10.1182\/blood.2023020912. Online ahead of print.","author":"Shea L, Mehta-Shah N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38142400"},{"title01":"Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in Adult T-cell leukemia\/lymphoma","title02":"Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in Adult T-cell leukemia\/lymphoma","journal":"Blood","issue":"2023 Dec 24:blood.2023021423. doi: 10.1182\/blood.2023021423. Online ahead of print.","author":"Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, Hasegawa H, Maeda M, Teshima T, Yang Y, Nakagawa M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38142436"},{"title01":"Anti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed\/Refractory Mature T-cell Lymphomas","title02":"Anti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed\/Refractory Mature T-cell Lymphomas","journal":"Blood","issue":"2023 Dec 25:blood.2023022204. doi: 10.1182\/blood.2023022204. Online ahead of print.","author":"Hill LC, Rouce RH, Wu M, Wang T, Ma R, Zhang H, Mehta B, Lapteva N, Mei Z, Smith TS, Yang L, Srinivasan M, Burkhardt PM, Ramos CA, Lulla PD, Arredondo M, Grilley B, Heslop HE, Brenner MK, Mamonkin M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38145560"},{"title01":"Cell crosstalk within lymphoma tumor microenvironment: follicular lymphoma as a paradigm","title02":"Cell crosstalk within lymphoma tumor microenvironment: follicular lymphoma as a paradigm","journal":"Blood","issue":"2023 Dec 14:blood.2023021000. doi: 10.1182\/blood.2023021000. Online ahead of print.","author":"Laurent C, Dietrich S, Tarte K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38096368"},{"title01":"Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma","title02":"Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma","journal":"Haematologica","issue":"2023 Dec 21. doi: 10.3324\/haematol.2023.283467. Online ahead of print.","author":"Chong PSY, Chooi JY, Lim SLJ, Chung TH, Brunmeir R, Leow ACY, Toh SHM, Balan K, Azaman MIB, Wu Z, Subramaniam N, Vardy LA, Chng WJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38124661"},{"title01":"T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails!","title02":"T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails!","journal":"Br J Haematol","issue":"2023 Dec 18. doi: 10.1111\/bjh.19267. Online ahead of print.","author":"Richter J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38111092"},{"title01":"Germline genetic variants in Turkish familial multiple myeloma\/monoclonal gammopathy of undetermined significance cases","title02":"Germline genetic variants in Turkish familial multiple myeloma\/monoclonal gammopathy of undetermined significance cases","journal":"Br J Haematol","issue":"2023 Dec 20. doi: 10.1111\/bjh.19271. Online ahead of print.","author":"Akkus E, Tuncal\u0131 T, Ak\u0131n HY, Ayd\u0131n Y, Be\u015f\u0131\u015f\u0131k SK, G\u00fcrkan E, Ratip S, Saliho\u011flu A, Sarg\u0131n D, \u00dcnal A, Turcan A, Sevindik \u00d6G, Demir M, Beksac M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38115798"},{"title01":"Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission","title02":"Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission","journal":"Leukemia","issue":"2023 Dec 21. doi: 10.1038\/s41375-023-02119-0. Online ahead of print.","author":"Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, Doki N, Yoshihara S, Katayama Y, Eto T, Tanaka M, Takada S, Kawakita T, Nishida T, Ota S, Serizawa K, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Konuma T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38129514"},{"title01":"Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","title02":"Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","journal":"Lancet Haematol","issue":"2023 Dec 21:S2352-3026(23)00344-7. doi: 10.1016\/S2352-3026(23)00344-7. Online ahead of print.","author":"Russo D, Schmitt M, Pilorge S, Stelljes M, Kawakita T, Teal VL, Haber B, Bopp C, Dadwal SS, Badshah C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38142695"},{"title01":"Living donor liver transplantation: 35 years of saving lives","title02":"Living donor liver transplantation: 35 years of saving lives","journal":"Lancet","issue":"2023 Dec 14:S0140-6736(23)01889-5. doi: 10.1016\/S0140-6736(23)01889-5. Online ahead of print.","author":"Raia S, Neto JS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38104573"},{"title01":"Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel","title02":"Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc<\/i> Italian expert panel","journal":"Haematologica","issue":"2023 Dec 14. doi: 10.3324\/haematol.2023.284417. Online ahead of print.","author":"Girmenia C, Ciceri F, Corradini P, Cuneo A, D'Ancona F, Musto P, Risitano AM, Voso MT, Venditti A, Barosi G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38105723"},{"title01":"T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails!","title02":"T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails!","journal":"Br J Haematol","issue":"2023 Dec 18. doi: 10.1111\/bjh.19267. Online ahead of print.","author":"Richter J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38111092"},{"title01":"Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation","title02":"Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation","journal":"Blood","issue":"2023 Dec 14:blood.2023022851. doi: 10.1182\/blood.2023022851. Online ahead of print.","author":"Dimitriou M, Mortera-Blanco T, Tobiasson M, Mazzi S, Lehander M, H\u00f6gstrand K, Karimi M, Walldin G, Jansson M, Vonlanthen S, Ljungman P, Langemeijer SMC, Yoshizato T, Hellstrom-Lindberg ES, Woll PS, Jacobsen SEW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38096358"},{"title01":"Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission","title02":"Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission","journal":"Leukemia","issue":"2023 Dec 21. doi: 10.1038\/s41375-023-02119-0. Online ahead of print.","author":"Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, Doki N, Yoshihara S, Katayama Y, Eto T, Tanaka M, Takada S, Kawakita T, Nishida T, Ota S, Serizawa K, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Konuma T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38129514"},{"title01":"Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis","title02":"Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis","journal":"Leukemia","issue":"2023 Dec 22. doi: 10.1038\/s41375-023-02121-6. Online ahead of print.","author":"Lee KH, Lee S, Park YH, Mun YC, Choi EJ, Choi Y, Park HS, Lee JH, Lee JH, Park SY, Yoon SR, Choi I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135760"},{"title01":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","title02":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","journal":"Lancet Haematol","issue":"2024 Jan;11(1):e12-e13.","author":"Chevallier P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135369"},{"title01":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","title02":"Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?","journal":"Lancet Haematol","issue":"2024 Jan;11(1):e13-e14.","author":"Boissel N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38135370"},{"title01":"Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","title02":"Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","journal":"Lancet Haematol","issue":"2023 Dec 21:S2352-3026(23)00344-7. doi: 10.1016\/S2352-3026(23)00344-7. Online ahead of print.","author":"Russo D, Schmitt M, Pilorge S, Stelljes M, Kawakita T, Teal VL, Haber B, Bopp C, Dadwal SS, Badshah C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38142695"},{"title01":"Skeletal stem-cell therapy: challenge meets opportunity","title02":"Skeletal stem-cell therapy: challenge meets opportunity","journal":"Lancet","issue":"2023 Dec 20:S0140-6736(23)02611-9. doi: 10.1016\/S0140-6736(23)02611-9. Online ahead of print.","author":"Cheng W, Huang J, Li N, Xu R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38141630"},{"title01":"Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel","title02":"Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc<\/i> Italian expert panel","journal":"Haematologica","issue":"2023 Dec 14. doi: 10.3324\/haematol.2023.284417. Online ahead of print.","author":"Girmenia C, Ciceri F, Corradini P, Cuneo A, D'Ancona F, Musto P, Risitano AM, Voso MT, Venditti A, Barosi G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38105723"},{"title01":"T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails!","title02":"T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails!","journal":"Br J Haematol","issue":"2023 Dec 18. doi: 10.1111\/bjh.19267. Online ahead of print.","author":"Richter J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38111092"},{"title01":"HCT alleviates disease burden in CGD","title02":"HCT alleviates disease burden in CGD","journal":"Blood","issue":"2023 Dec 14;142(24):2043-2045.","author":"G\u00fcng\u00f6r T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38095925"},{"title01":"Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation","title02":"Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation","journal":"Blood","issue":"2023 Dec 14:blood.2023022851. doi: 10.1182\/blood.2023022851. Online ahead of print.","author":"Dimitriou M, Mortera-Blanco T, Tobiasson M, Mazzi S, Lehander M, H\u00f6gstrand K, Karimi M, Walldin G, Jansson M, Vonlanthen S, Ljungman P, Langemeijer SMC, Yoshizato T, Hellstrom-Lindberg ES, Woll PS, Jacobsen SEW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38096358"},{"title01":"Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France","title02":"Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France","journal":"Br J Haematol","issue":"2023 Dec 14. doi: 10.1111\/bjh.19242. Online ahead of print.","author":"Hansen DL, Maquet J, Lafaurie M, M\u00f6ller S, Berentsen S, Frederiksen H, Moulis G, Gaist D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38098244"},{"title01":"Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice","title02":"Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice","journal":"Blood","issue":"2023 Dec 24:blood.2023021583. doi: 10.1182\/blood.2023021583. Online ahead of print.","author":"Shi H, Gao L, Kirby N, Shao B, Shan X, Kudo M, Silasi R, McDaniel MJ, Zhou M, McGee S, Jing W, Lupu F, Cleuren A, George JN, Xia L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38142410"},{"title01":"Efficacy of combined low-dose ruxolitinib and cyclosporine in murine immune bone marrow failure","title02":"Efficacy of combined low-dose ruxolitinib and cyclosporine in murine immune bone marrow failure","journal":"Haematologica","issue":"2023 Dec 28. doi: 10.3324\/haematol.2023.284358. Online ahead of print.","author":"Feng X, Manley AL, Wu Z, Li H, Gao S, Durrani J, Aggarwal N, Mizumaki H, Chen J, Young NS, Groarke EM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38152039"},{"title01":"PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression","title02":"PELI2<\/i> regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression","journal":"Haematologica","issue":"2023 Dec 7. doi: 10.3324\/haematol.2023.284041. Online ahead of print.","author":"Xu Y, Zhou Q, Wang X, Zhang A, Qi W, Li Y, Zheng C, Guan J, Sun T, Li J, Lu C, Shen Y, Zhao B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38058209"},{"title01":"Dual-receptor T cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML","title02":"Dual-receptor T cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML","journal":"Blood","issue":"2023 Dec 4:blood.2023021054. doi: 10.1182\/blood.2023021054. Online ahead of print.","author":"Dao T, Xiong G, Mun SS, Meyerberg J, Korontsvit T, Xiang J, Cui Z, Chang AY, Jarvis CA, Cai W, Luo H, Pierson AJ, Daniyan AF, Yoo S, Takao S, Kharas MG, Kentsis A, Liu C, Scheinberg DA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048594"},{"title01":"Intravascular Large B-Cell Lymphoma","title02":"Intravascular Large B-Cell Lymphoma","journal":"N Engl J Med","issue":"2023 Dec 7;389(23):2188.","author":"Cheng JW, Li JH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38055255"},{"title01":"FDA investigates risk of secondary lymphomas after CAR-T immunotherapy","title02":"FDA investigates risk of secondary lymphomas after CAR-T immunotherapy","journal":"Lancet Oncol","issue":"2023 Dec 7:S1470-2045(23)00631-9. doi: 10.1016\/S1470-2045(23)00631-9. Online ahead of print.","author":"Furlow B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38071995"},{"title01":"Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study","title02":"Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study","journal":"Lancet Oncol","issue":"2023 Dec 7:S1470-2045(23)00589-2. doi: 10.1016\/S1470-2045(23)00589-2. Online ahead of print.","author":"Song Y, Malpica L, Cai Q, Zhao W, Zhou K, Wu J, Zhang H, Mehta-Shah N, Ding K, Liu Y, Li Z, Zhang L, Zheng M, Jin J, Yang H, Shuang Y, Yoon DH, Gao S, Li W, Zhai Z, Zou L, Xi Y, Koh Y, Li F, Prince M, Zhou H, Lin L, Liu H, Allen P, Roncolato F, Yang Z, Kim WS, Zhu J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38092009"},{"title01":"Lisocabtagene Maraleucel in Relapsed\/Refractory Mantle Cell Lymphoma (MCL): Primary Analysis of the MCL Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study","title02":"Lisocabtagene Maraleucel in Relapsed\/Refractory Mantle Cell Lymphoma (MCL): Primary Analysis of the MCL Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study","journal":"J Clin Oncol","issue":"2023 Dec 10:101200JCO2302214. doi: 10.1200\/JCO.23.02214. Online ahead of print.","author":"Wang M, Siddiqi T, Gordon LI, Kamdar M, Lunning M, Hirayama AV, Abramson JS, Arnason J, Ghosh N, Mehta A, Andreadis C, Solomon SR, Kostic A, Dehner C, Espinola R, Peng L, Ogasawara K, Chattin A, Eliason L, Palomba ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38072625"},{"title01":"CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton’s Tyrosine Kinase Inhibition","title02":"CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton’s Tyrosine Kinase Inhibition","journal":"J Clin Oncol","issue":"2023 Dec 11:JCO2301574. doi: 10.1200\/JCO.23.01574. Online ahead of print.","author":"Cooper A, Tumuluru S, Kissick K, Venkataraman G, Song JY, Lytle A, Duns G, Yu J, Kotlov N, Bagaev A, Hodkinson B, Srinivasan S, Smith SM, Scott DW, Steidl C, Godfrey JK, Kline J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38079587"},{"title01":"Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes","title02":"Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes","journal":"J Clin Oncol","issue":"2023 Dec 6:JCO2301053. doi: 10.1200\/JCO.23.01053. Online ahead of print.","author":"Noerenberg D, Briest F, Hennch C, Yoshida K, Hablesreiter R, Takeuchi Y, Ueno H, Staiger AM, Ziepert M, Asmar F, Locher BN, Toth E, Weber T, Amini RM, Klapper W, Bouzani M, Poeschel V, Rosenwald A, Held G, Campo E, Ishaque N, Stamatopoulos K, Kanellis G, Anagnostopoulos I, Bullinger L, Goldschmidt N, Zinzani PL, B\u00f6d\u00f6r C, Rosenquist R, Vassilakopoulos TP, Ott G, Ogawa S, Damm F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38055913"},{"title01":"Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","title02":"Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization","journal":"Haematologica","issue":"2023 Dec 1;108(12):3204-3210.","author":"Savage KJ, De Leval L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037798"},{"title01":"Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas","title02":"Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas","journal":"Haematologica","issue":"2023 Dec 1;108(12):3211-3226.","author":"Ngu HS, Savage KJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037799"},{"title01":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","title02":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","journal":"Haematologica","issue":"2023 Dec 1;108(12):3227-3243.","author":"Bisig B, Savage KJ, De Leval L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037800"},{"title01":"Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas","title02":"Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas","journal":"Haematologica","issue":"2023 Dec 1;108(12):3244-3260.","author":"Stuver R, Epstein-Peterson ZD, Horwitz SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037801"},{"title01":"Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders","title02":"Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders","journal":"Haematologica","issue":"2023 Dec 1;108(12):3261-3277.","author":"Lewis NE, Zhou T, Dogan A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037802"},{"title01":"miR-101-5p modulation of CD47 in diffuse large B-cell lymphoma: Implications for anti-CD47 immunotherapy and prognostication","title02":"miR-101-5p modulation of CD47 in diffuse large B-cell lymphoma: Implications for anti-CD47 immunotherapy and prognostication","journal":"Br J Haematol","issue":"2023 Dec 12. doi: 10.1111\/bjh.19264. Online ahead of print.","author":"Masroni MSB, Leong SM, Cheng H, Lim GS, Heng NZY, Law CT, Ashraff S, Tan SY, Hue SSS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38087456"},{"title01":"Primary central nervous system marginal zone lymphoma","title02":"Primary central nervous system marginal zone lymphoma","journal":"Br J Haematol","issue":"2023 Dec 6. doi: 10.1111\/bjh.19238. Online ahead of print.","author":"Flospergher E, Marino F, Calimeri T, Cangi MG, Ferreri AJM, Ponzoni M, Bongiovanni L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38054330"},{"title01":"A peculiar case of cyclin D1-positive lymphoplasmacytic lymphoma","title02":"A peculiar case of cyclin D1-positive lymphoplasmacytic lymphoma","journal":"Blood","issue":"2023 Dec 7;142(23):2034.","author":"Luu BE, Xu SA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38060270"},{"title01":"What’s brewing for MALT1 in lymphoma?","title02":"What’s brewing for MALT1 in lymphoma?","journal":"Blood","issue":"2023 Dec 7;142(23):1939-1941.","author":"Spaargaren M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38060274"},{"title01":"Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma","title02":"Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma","journal":"Blood","issue":"2023 Nov 30;142(22):1935.","author":"Cai J, Lee J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38032669"},{"title01":"EGR1 changes course in B-cell lymphoma","title02":"EGR1 changes course in B-cell lymphoma","journal":"Blood","issue":"2023 Nov 30;142(22):1850-1851.","author":"Rauert-Wunderlich H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38032671"},{"title01":"Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed\/refractory B-cell lymphomas","title02":"Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed\/refractory B-cell lymphomas","journal":"Blood","issue":"2023 Dec 4:blood.2023022348. doi: 10.1182\/blood.2023022348. Online ahead of print.","author":"Schuster SJ, Huw LY, Bolen CR, Maximov V, Polson AG, Hatzi K, Lasater EA, Assouline SE, Bartlett NL, Budde LEE, Matasar MJ, Koeppen H, Piccione EC, Wilson D, Wei MC, Yin S, Penuel E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048694"},{"title01":"Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma","title02":"Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma","journal":"N Engl J Med","issue":"2023 Dec 12. doi: 10.1056\/NEJMoa2312054. Online ahead of print.","author":"Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosi\u00f1ol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Blad\u00e9 J, Moreau P; PERSEUS Trial Investigators.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38084760"},{"title01":"Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients","title02":"Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients","journal":"Leukemia","issue":"2023 Dec 7. doi: 10.1038\/s41375-023-02105-6. Online ahead of print.","author":"Mai EK, Hielscher T, Bertsch U, Salwender HJ, Zweegman S, Raab MS, Munder M, Pantani L, Mancuso K, Brossart P, Beksac M, Blau IW, D\u00fcrig J, Besemer B, Fenk R, Reimer P, van der Holt B, H\u00e4nel M, von Metzler I, Graeven U, M\u00fcller-Tidow C, Boccadoro M, Scheid C, Dimopoulos MA, Hillengass J, Weisel KC, Cavo M, Sonneveld P, Goldschmidt H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38062124"},{"title01":"Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients","title02":"Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients","journal":"Leukemia","issue":"2023 Dec 4. doi: 10.1038\/s41375-023-02070-0. Online ahead of print.","author":"Enssle JC, Campe J, Moter A, Voit I, Gessner A, Yu W, Wolf S, Steffen B, Serve H, Bremm M, Huenecke S, Lohoff M, Vehreschild M, Rabenau HF, Widera M, Ciesek S, Oellerich T, Imkeller K, Rieger MA, von Metzler I, Ullrich E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38049509"},{"title01":"Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma","title02":"Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma","journal":"Br J Haematol","issue":"2023 Nov 30. doi: 10.1111\/bjh.19227. Online ahead of print.","author":"Bal S, Costa LJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38036424"},{"title01":"An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma","title02":"An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma","journal":"Br J Haematol","issue":"2023 Dec 5. doi: 10.1111\/bjh.19240. Online ahead of print.","author":"Li M, Bennett MK, Toubia J, Pope VS, Tea MN, Tamang S, Samuel MS, Anderson PH, Gliddon BL, Powell JA, Pitson SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38053270"},{"title01":"Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation","title02":"Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation","journal":"Br J Haematol","issue":"2023 Dec 6. doi: 10.1111\/bjh.19244. Online ahead of print.","author":"Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38054558"},{"title01":"CAR T-Cell Therapy in Multiple Myeloma: Mission Accomplished?","title02":"CAR T-Cell Therapy in Multiple Myeloma: Mission Accomplished?","journal":"Blood","issue":"2023 Nov 30:blood.2023021221. doi: 10.1182\/blood.2023021221. Online ahead of print.","author":"Rasche L, Hudecek M, Einsele H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38033289"},{"title01":"Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients","title02":"Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients","journal":"Blood","issue":"2023 Dec 4:blood.2023022083. doi: 10.1182\/blood.2023022083. Online ahead of print.","author":"Guerrero C, Puig N, Cedena MT, Calasanz MJ, Gutierrez NC, Fernandez M, Oriol A, R\u00edos-Tamayo R, Hernandez Garcia MT, Mart\u00ednez-Mart\u00ednez R, Bargay J, de Arriba F, Palomera L, Gonzalez-Rodriguez AP, Gonzalez Perez MS, Orfao A, Mateos MV, Martinez-Lopez J, Rosi\u00f1ol L, Blad\u00e9 J, Lahuerta JJ, San-Miguel J, Paiva B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048552"},{"title01":"Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients","title02":"Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients","journal":"Blood","issue":"2023 Dec 4:blood.2023022080. doi: 10.1182\/blood.2023022080. Online ahead of print.","author":"D'Agostino M, Bertuglia G, Rota-Scalabrini D, Belotti A, Mor\u00e8 S, Corradini P, Oliva S, Ledda A, Grasso M, Pavone V, Ronconi S, Vincelli ID, Ballanti S, Velluti C, Cellini C, Gozzetti A, Palmas AD, Gamberi B, Mancuso K, Paris L, Zambello R, Petrucci MT, Bruno B, Musto P, Gay F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048557"},{"title01":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT\/ELN International Working Group","title02":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT\/ELN International Working Group","journal":"Lancet Haematol","issue":"2023 Dec 4:S2352-3026(23)00305-8. doi: 10.1016\/S2352-3026(23)00305-8. Online ahead of print.","author":"Kr\u00f6ger N, Bacigalupo A, Barbui T, Ditschkowski M, Gagelmann N, Griesshammer M, Gupta V, Hamad N, Harrison C, Hernandez-Boluda JC, Koschmieder S, Jain T, Mascarenhas J, Mesa R, Popat UR, Passamonti F, Polverelli N, Rambaldi A, Robin M, Salit RB, Schroeder T, Scott BL, Tamari R, Tefferi A, Vannucchi AM, McLornan DP, Barosi G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38061384"},{"title01":"HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation","title02":"HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation","journal":"J Clin Oncol","issue":"2023 Dec 5:JCO2301264. doi: 10.1200\/JCO.23.01264. Online ahead of print.","author":"Petersdorf EW, McKallor C, Malkki M, He M, Spellman SR, Gooley T, Stevenson P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38051980"},{"title01":"Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome\/venous occlusive disease","title02":"Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome\/venous occlusive disease","journal":"Haematologica","issue":"2023 Dec 7. doi: 10.3324\/haematol.2023.284310. Online ahead of print.","author":"Kayser S, Sartor C, Giglio F, Bruno A, Webster J, Chiusolo P, Saraceni F, Guerzoni S, Pochintesta L, Borlenghi E, Marconi G, Zacheo I, Cerrano M, Salutari P, Restuccia F, Abbenante M, Levis MJ, Schlenk RF, Papayannidis C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38058184"},{"title01":"Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making","title02":"Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making","journal":"Br J Haematol","issue":"2023 Dec 9. doi: 10.1111\/bjh.19200. Online ahead of print.","author":"Civettini I, Zappaterra A, Granelli BM, Rindone G, Aroldi A, Bonfanti S, Colombo F, Fedele M, Grillo G, Parma M, Perfetti P, Terruzzi E, Gambacorti-Passerini C, Ramazzotti D, Cavalca F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38070128"},{"title01":"Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation","title02":"Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation","journal":"Br J Haematol","issue":"2023 Nov 30. doi: 10.1111\/bjh.19228. Online ahead of print.","author":"Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037468"},{"title01":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","title02":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2023 Dec 5. doi: 10.1111\/bjh.19223. Online ahead of print.","author":"Wang Z, Fan Z, Wu Z, Xuan L, Li X, Tang B, Liu Y, He J, Huang K, Zhou X, Gao Y, Wang Q, Li X, Lin R, Xu N, Huang F, Wang S, Liang X, Zhang J, Liu X, Sun J, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38050437"},{"title01":"A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL","title02":"A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL","journal":"Br J Haematol","issue":"2023 Dec 6. doi: 10.1111\/bjh.19231. Online ahead of print.","author":"Fuji S, Yuda S, Tada Y, Kano M, Sanda K, Fujishita K, Terakawa T, Shingai Y, Kasahara H, Yokota T, Ishikawa J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38053439"},{"title01":"Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation","title02":"Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation","journal":"Br J Haematol","issue":"2023 Dec 6. doi: 10.1111\/bjh.19244. Online ahead of print.","author":"Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38054558"},{"title01":"Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients","title02":"Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients","journal":"Blood","issue":"2023 Dec 4:blood.2023022083. doi: 10.1182\/blood.2023022083. Online ahead of print.","author":"Guerrero C, Puig N, Cedena MT, Calasanz MJ, Gutierrez NC, Fernandez M, Oriol A, R\u00edos-Tamayo R, Hernandez Garcia MT, Mart\u00ednez-Mart\u00ednez R, Bargay J, de Arriba F, Palomera L, Gonzalez-Rodriguez AP, Gonzalez Perez MS, Orfao A, Mateos MV, Martinez-Lopez J, Rosi\u00f1ol L, Blad\u00e9 J, Lahuerta JJ, San-Miguel J, Paiva B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048552"},{"title01":"CSF1R inhibition promotes neuroinflammation and behavioural deficits during graft-versus-host disease in mice","title02":"CSF1R inhibition promotes neuroinflammation and behavioural deficits during graft-versus-host disease in mice","journal":"Blood","issue":"2023 Dec 4:blood.2023022040. doi: 10.1182\/blood.2023022040. Online ahead of print.","author":"Adams RC, Carter-Cusack D Mr, Llanes GT, Hunter CR, Vinnakota JM, Ruitenberg MJ, Vukovic J, Bertolino P, Chand KK, Wixey JA, Nayler SP, Hill GR, Furlan SN, Zeiser R, MacDonald KPA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048572"},{"title01":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT\/ELN International Working Group","title02":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT\/ELN International Working Group","journal":"Lancet Haematol","issue":"2023 Dec 4:S2352-3026(23)00305-8. doi: 10.1016\/S2352-3026(23)00305-8. Online ahead of print.","author":"Kr\u00f6ger N, Bacigalupo A, Barbui T, Ditschkowski M, Gagelmann N, Griesshammer M, Gupta V, Hamad N, Harrison C, Hernandez-Boluda JC, Koschmieder S, Jain T, Mascarenhas J, Mesa R, Popat UR, Passamonti F, Polverelli N, Rambaldi A, Robin M, Salit RB, Schroeder T, Scott BL, Tamari R, Tefferi A, Vannucchi AM, McLornan DP, Barosi G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38061384"},{"title01":"HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation","title02":"HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation","journal":"J Clin Oncol","issue":"2023 Dec 5:JCO2301264. doi: 10.1200\/JCO.23.01264. Online ahead of print.","author":"Petersdorf EW, McKallor C, Malkki M, He M, Spellman SR, Gooley T, Stevenson P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38051980"},{"title01":"Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome\/venous occlusive disease","title02":"Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome\/venous occlusive disease","journal":"Haematologica","issue":"2023 Dec 7. doi: 10.3324\/haematol.2023.284310. Online ahead of print.","author":"Kayser S, Sartor C, Giglio F, Bruno A, Webster J, Chiusolo P, Saraceni F, Guerzoni S, Pochintesta L, Borlenghi E, Marconi G, Zacheo I, Cerrano M, Salutari P, Restuccia F, Abbenante M, Levis MJ, Schlenk RF, Papayannidis C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38058184"},{"title01":"A defined serum-free culture system for human long-term haematopoietic stem cells","title02":"A defined serum-free culture system for human long-term haematopoietic stem cells","journal":"Br J Haematol","issue":"2023 Dec 8. doi: 10.1111\/bjh.19204. Online ahead of print.","author":"Dong Y, Cai R, Fang M, Chen Y, Li P, Guo C, Ma X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38066715"},{"title01":"Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making","title02":"Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making","journal":"Br J Haematol","issue":"2023 Dec 9. doi: 10.1111\/bjh.19200. Online ahead of print.","author":"Civettini I, Zappaterra A, Granelli BM, Rindone G, Aroldi A, Bonfanti S, Colombo F, Fedele M, Grillo G, Parma M, Perfetti P, Terruzzi E, Gambacorti-Passerini C, Ramazzotti D, Cavalca F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38070128"},{"title01":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","title02":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2023 Dec 5. doi: 10.1111\/bjh.19223. Online ahead of print.","author":"Wang Z, Fan Z, Wu Z, Xuan L, Li X, Tang B, Liu Y, He J, Huang K, Zhou X, Gao Y, Wang Q, Li X, Lin R, Xu N, Huang F, Wang S, Liang X, Zhang J, Liu X, Sun J, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38050437"},{"title01":"Granulocyte transfusions in severe aplastic anemia","title02":"Granulocyte transfusions in severe aplastic anemia","journal":"Haematologica","issue":"2023 Dec 7. doi: 10.3324\/haematol.2023.283826. Online ahead of print.","author":"Rajput RV, Shah V, Shalhoub RN, West-Mitchell K, Cha NR, Conry-Cantilena C, Leitman SF, Young DJ, Wells B, Aue G, Dunbar CE, Patel BA, Childs RW, Young NS, Wu CO, Groarke EM, Kalsi SS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38058170"},{"title01":"Revisiting the first reported case of aplastic anaemia","title02":"Revisiting the first reported case of aplastic anaemia","journal":"Br J Haematol","issue":"2023 Dec 3. doi: 10.1111\/bjh.19241. Online ahead of print.","author":"Steensma DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38044033"},{"title01":"Long-term eltrombopag in children with chronic immune thrombocytopenia: A single-centre extended real-life observational study in China","title02":"Long-term eltrombopag in children with chronic immune thrombocytopenia: A single-centre extended real-life observational study in China","journal":"Br J Haematol","issue":"2023 Dec 12. doi: 10.1111\/bjh.19253. Online ahead of print.","author":"Wang Z, Wang N, Juntao O, Ma J, Dong S, Meng J, Liu J, Chen Z, Cheng X, Wu R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38087811"},{"title01":"Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses","title02":"Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses","journal":"Br J Haematol","issue":"2023 Nov 30. doi: 10.1111\/bjh.19229. Online ahead of print.","author":"Ou Y, Zhan Y, Shao X, Xu P, Ji L, Zhuang X, Chen H, Cheng Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38031970"},{"title01":"Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease","title02":"Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease","journal":"N Engl J Med","issue":"2023 Dec 10. doi: 10.1056\/NEJMoa2310063. Online ahead of print.","author":"Munir T, Cairns DA, Bloor A, Allsup D, Cwynarski K, Pettitt A, Paneesha S, Fox CP, Eyre TA, Forconi F, Elmusharaf N, Kennedy B, Gribben J, Pemberton N, Sheehy O, Preston G, Schuh A, Walewska R, Duley L, Howard D, Hockaday A, Jackson S, Greatorex N, Girvan S, Bell S, Brown JM, Webster N, Dalal S, de Tute R, Rawstron A, Patten PEM, Hillmen P; National Cancer Research Institute Chronic Lymphocytic Leukemia Subgroup.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38078508"},{"title01":"Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia","title02":"Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia","journal":"Leukemia","issue":"2023 Dec 8. doi: 10.1038\/s41375-023-02104-7. Online ahead of print.","author":"Kovtun I, von Bonin M, Ibneeva L, Frimmel J, Middeke JM, Kunadt D, Heberling L, Wobus M, Bornh\u00e4user M, Grinenko T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38066329"},{"title01":"Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia","title02":"Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia","journal":"Leukemia","issue":"2023 Dec 12. doi: 10.1038\/s41375-023-02102-9. Online ahead of print.","author":"Hoffmeister LM, Suttorp J, Walter C, Antoniou E, Behrens YL, G\u00f6hring G, Awada A, von Neuhoff N, Reinhardt D, Schneider M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38086945"},{"title01":"Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression","title02":"Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression","journal":"Leukemia","issue":"2023 Dec 12. doi: 10.1038\/s41375-023-02108-3. Online ahead of print.","author":"Birdwell CE, Fiskus W, Kadia TM, Mill CP, Sasaki K, Daver N, DiNardo CD, Pemmaraju N, Borthakur G, Davis JA, Das K, Sharma S, Horrigan S, Ruan X, Su X, Khoury JD, Kantarjian H, Bhalla KN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38086946"},{"title01":"The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia","title02":"The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia","journal":"Leukemia","issue":"2023 Nov 30. doi: 10.1038\/s41375-023-02098-2. Online ahead of print.","author":"Miliara S, Cozzi E, Zhong X, Chan I, Ekwall K, Lehmann S, Lennartsson A, Bartek J, Kanellis DC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38036629"},{"title01":"Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States","title02":"Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States","journal":"Leukemia","issue":"2023 Dec 4. doi: 10.1038\/s41375-023-02100-x. Online ahead of print.","author":"Saba L, Landau KS, Liang H, Fu CL, Chaulagain CP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38049508"},{"title01":"ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia","title02":"ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia","journal":"Leukemia","issue":"2023 Dec 6. doi: 10.1038\/s41375-023-02103-8. Online ahead of print.","author":"Tannoury M, Ayoub M, Dehgane L, Nemazanyy I, Dubois K, Izabelle C, Brousse A, Roos-Weil D, Maloum K, Merle-B\u00e9ral H, Bauvois B, Saubamea B, Chapiro E, Nguyen-Khac F, Garnier D, Susin SA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38057495"},{"title01":"CML and the WHO: Why?","title02":"CML and the WHO: Why?","journal":"J Clin Oncol","issue":"2023 Dec 12:JCO2301689. doi: 10.1200\/JCO.23.01689. Online ahead of print.","author":"Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, Bhatia R, Chan O, Collins R, Curtin P, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore J, Oehler V, Pratz K, Pusic I, Rose M, Shomali W, Smith BD, Styler M, Sweet K, Talpaz M, Tanaka T, Tantravahi S, Tsai S, Vaughn J, Welborn J, Yang D, Mauro M, Cortes J, Radich J, Druker B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38086008"},{"title01":"Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054\/COG AAML1921","title02":"Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054\/COG AAML1921","journal":"J Clin Oncol","issue":"2023 Nov 30:JCO2300897. doi: 10.1200\/JCO.23.00897. Online ahead of print.","author":"Brivio E, Pennesi E, Willemse ME, Huitema ADR, Jiang Y, van Tinteren HDR, van der Velden VHJ, Beverloo BH, den Boer ML, Rammeloo LAJ, Hudson C, Heerema N, Kowalski K, Zhao H, Kuttschreuter L, Bautista Sirvent FJ, Bukowinski A, Rizzari C, Pollard J, Murillo-Sanju\u00e1n L, Kutny M, Zarnegar-Lumley S, Redell M, Cooper S, Bertrand Y, Petit A, Krystal J, Metzler M, Lancaster D, Bourquin JP, Motwani J, van der Sluis IM, Locatelli F, Roth ME, Hijiya N, Zwaan CM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38033284"},{"title01":"Clonal evolution of leukemia from G6PD studies","title02":"Clonal evolution of leukemia from G6PD studies","journal":"Haematologica","issue":"2023 Dec 1;108(12):3191-3192.","author":"Bacharach T, Shlush LI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38037797"},{"title01":"Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome\/venous occlusive disease","title02":"Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome\/venous occlusive disease","journal":"Haematologica","issue":"2023 Dec 7. doi: 10.3324\/haematol.2023.284310. Online ahead of print.","author":"Kayser S, Sartor C, Giglio F, Bruno A, Webster J, Chiusolo P, Saraceni F, Guerzoni S, Pochintesta L, Borlenghi E, Marconi G, Zacheo I, Cerrano M, Salutari P, Restuccia F, Abbenante M, Levis MJ, Schlenk RF, Papayannidis C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38058184"},{"title01":"CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia","title02":"CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia","journal":"Haematologica","issue":"2023 Dec 7. doi: 10.3324\/haematol.2023.282854. Online ahead of print.","author":"Cardoso BA, Duque M, G\u00edrio A, Fragoso R, Oliveira ML, Allen JR, Martins LR, Correia NC, Silveira AB, Veloso A, Kimura S, Demoen L, Matthijssens F, Jeha S, Cheng C, Pui CH, Grosso AR, Neto JL, De Almeida SF, Van Vlieberghe P, Mullighan CG, Yunes JA, Langenau DM, Pflumio F, Barata JT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38058200"},{"title01":"Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-na\u00efve CLL patients","title02":"Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-na\u00efve CLL patients","journal":"Br J Haematol","issue":"2023 Dec 7. doi: 10.1111\/bjh.19191. Online ahead of print.","author":"Navrkalova V, Plevova K, Radova L, Porc J, Pal K, Malcikova J, Pavlova S, Doubek M, Panovska A, Kotaskova J, Pospisilova S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38062779"},{"title01":"Should oligomonocytic CMML be classified as an independent disease entity?","title02":"Should oligomonocytic CMML be classified as an independent disease entity?","journal":"Br J Haematol","issue":"2023 Dec 8. doi: 10.1111\/bjh.19254. Online ahead of print.","author":"Zhao HG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38066684"},{"title01":"Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors","title02":"Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors","journal":"Br J Haematol","issue":"2023 Dec 10. doi: 10.1111\/bjh.19250. Online ahead of print.","author":"Madero-Marroquin R, DuVall AS, Saygin C, Wang P, Gurbuxani S, Larson RA, Stock W, Patel AA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38073116"},{"title01":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","title02":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2023 Dec 5. doi: 10.1111\/bjh.19223. Online ahead of print.","author":"Wang Z, Fan Z, Wu Z, Xuan L, Li X, Tang B, Liu Y, He J, Huang K, Zhou X, Gao Y, Wang Q, Li X, Lin R, Xu N, Huang F, Wang S, Liang X, Zhang J, Liu X, Sun J, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38050437"},{"title01":"Early clearance of hairy cell leukaemia in the bone marrow after first-line treatment with cladribine predicts a favourable outcome","title02":"Early clearance of hairy cell leukaemia in the bone marrow after first-line treatment with cladribine predicts a favourable outcome","journal":"Br J Haematol","issue":"2023 Dec 4. doi: 10.1111\/bjh.19237. Online ahead of print.","author":"Ligia S, Passucci M, Assanto GM, D'Elia GM, Annechini G, De Propris MS, Martelli M, Del Giudice I, Tiacci E, Pulsoni A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38050458"},{"title01":"A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL","title02":"A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL","journal":"Br J Haematol","issue":"2023 Dec 6. doi: 10.1111\/bjh.19231. Online ahead of print.","author":"Fuji S, Yuda S, Tada Y, Kano M, Sanda K, Fujishita K, Terakawa T, Shingai Y, Kasahara H, Yokota T, Ishikawa J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38053439"},{"title01":"Distinct karyotypic and mutational landscape in trisomy AML","title02":"Distinct karyotypic and mutational landscape in trisomy AML","journal":"Br J Haematol","issue":"2023 Dec 6. doi: 10.1111\/bjh.19249. Online ahead of print.","author":"Lam SSY, Tsui SP, Fung CY, Saw NY, Javed A, Ip AHW, Ma ESK, Leung AYH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38054248"},{"title01":"PLK4, a potential target against AML","title02":"PLK4, a potential target against AML","journal":"Blood","issue":"2023 Dec 7;142(23):1941-1942.","author":"Palm-Apergi C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38060272"},{"title01":"Determining Treatment Tolerance and Fitness for Intensive Chemotherapy in Older Adults with AML: A Call to Action","title02":"Determining Treatment Tolerance and Fitness for Intensive Chemotherapy in Older Adults with AML: A Call to Action","journal":"Blood","issue":"2023 Dec 4:blood.2023022611. doi: 10.1182\/blood.2023022611. Online ahead of print.","author":"Bhatt VR, Uy GL, Klepin HD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38048592"}]